+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 10494

Chapter 10494 contains a list of PDF Full Texts available from EurekaMag.





Chen, X.; Edwards, J.A.S.; Logsdon, C.D.; Ernst, S.A.; Williams, J.A., 2002:
Dominant negative Rab3D inhibits amylase release from mouse pancreatic acini

Ding, W.Q.n; Kuntz, S.; Boehmig, M.; Wiedenmann, B.; Miller, L.J., 2002:
Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma

Burgos-Trinidad, M.; Koenig, R.J., 1999:
Dominant negative activity of thyroid hormone receptor variant alpha2 and interaction with nuclear corepressors

Scherer-Oppliger, T.; Matasovic, A.; Laufs, S.; Levy, H.L.; Quackenbush, E.J.; Blau, N.; Thöny, B., 1999:
Dominant negative allele (N47D) in a compound heterozygote for a variant of 6-pyruvoyltetrahydropterin synthase deficiency causing transient hyperphenylalaninemia

Ioroi, T.; Yamamori, M.; Yagi, K.; Hirai, M.; Zhan, Y.; Kim, S.; Iwao, H., 2003:
Dominant negative c-Jun inhibits platelet-derived growth factor-directed migration by vascular smooth muscle cells

Hennigan, R.F.; Stambrook, P.J., 2001:
Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes

Saadi, I.; Kuburas, A.; Engle, J.J.; Russo, A.F., 2003:
Dominant negative dimerization of a mutant homeodomain protein in Axenfeld-Rieger syndrome

Yuan, Q.; Zhao, F.; Chung, S.W.; Fan, P.; Sultzer, B.M.; Kan, Y.W.; Wong, P.M., 2000:
Dominant negative down-regulation of endotoxin-induced tumor necrosis factor alpha production by Lps(d)/Ran

Shimizu, R.; Komatsu, N.; Miura, Y., 1999:
Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: Possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome

Dihlmann, S.; Gebert, J.; Siermann, A.; Herfarth, C.; von Knebel Doeberitz, M., 1999:
Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis

Bernard-Pierrot, I.; Delbé, J.; Rouet, V.; Vigny, M.; Kerros, M-Emmanuelle.; Caruelle, Dèle.; Raulais, D.; Barritault, D.; Courty, Jé.; Milhiet, P.Emmanuel., 2002:
Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities

Buttini, M.; Akeefe, H.; Lin, C.; Mahley, R.W.; Pitas, R.E.; Wyss Coray, T.; Mucke, L., 2000:
Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease

Solomon, C.S.; Goalstone, M.L., 2001:
Dominant negative farnesyltransferase alpha-subunit inhibits insulin mitogenic effects

Kotani, K.; Ogawa, W.; Hino, Y.; Kitamura, T.; Ueno, H.; Sano, W.; Sutherland, C.; Granner, D.K.; Kasuga, M., 1999:
Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Clambda do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription

Li, S.; Koromilas, A.E., 2001:
Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR

Zhu, C.H.ng; Domann, F.E., 2002:
Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth

Kitayama, S.; Ikeda, T.; Mitsuhata, C.; Sato, T.; Morita, K.; Dohi, T., 1999:
Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing

Nakase, K.; Ishimaru, F.; Avitahl, N.; Dansako, H.; Matsuo, K.; Fujii, K.; Sezaki, N.; Nakayama, H.; Yano, T.; Fukuda, S.; Imajoh, K.; Takeuchi, M.; Miyata, A.; Hara, M.; Yasukawa, M.; Takahashi, I.; Taguchi, H.; Matsue, K.; Nakao, S.; Niho, Y.; Takenaka, K.; Shinagawa, K.; Ikeda, K.; Niiya, K.; Harada, M., 2000:
Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia

Belaguli, N.S.; Zhou, W.; Trinh, T.H.; Majesky, M.W.; Schwartz, R.J., 1999:
Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets

Miyamoto, A.; Matsuyama, S.I.hi; Tokuda, H., 2002:
Dominant negative mutant of a lipoprotein-specific molecular chaperone, LolA, tightly associates with LolCDE

Omura, T.; Yoshiyama, M.; Yoshida, K.; Nakamura, Y.; Kim, S.; Iwao, H.; Takeuchi, K.; Yoshikawa, J., 2002:
Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine

Ilaria, R.L.; Hawley, R.G.; Van Etten, R.A., 1999:
Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation

Lin, R.; Canfield, V.; Levenson, R., 2002:
Dominant negative mutants of filamin A block cell surface expression of the D2 dopamine receptor

Yuen, P.S., 1999:
Dominant negative mutants of guanylyl cyclase: probes for global functions and intramolecular mechanisms

von Weizsäcker, F.; Köck, J.; Wieland, S.; Offensperger, W.B.; Blum, H.E., 1999 :
Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis

Edwalds-Gilbert, G.; Kim, D.H.; Kim, S.H.; Tseng, Y.H.; Yu, Y.; Lin, R.J., 2000:
Dominant negative mutants of the yeast splicing factor Prp2 map to a putative cleft region in the helicase domain of DExD/H-box proteins

Williams, D.A.; Tao, W.; Yang, F.; Kim, C.; Gu, Y.; Mansfield, P.; Levine, J.E.; Petryniak, B.; Derrow, C.W.; Harris, C.; Jia, B.; Zheng, Y.; Ambruso, D.R.; Lowe, J.B.; Atkinson, S.J.; Dinauer, M.C.; Boxer, L., 2000:
Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency

Barroso, I.; Gurnell, M.; Crowley, V.E.F.; Agostini, M.; Schwabe, J.W.; Soos, M.A.; Maslen, G.L.; Williams, T.D.M.; Lewis, H.; Schafer, A.J.; Chatterjee, V.K.K.; O'rahilly, S., 1999:
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

Leavitt, L.M.; Macaluso, C.R.; Kim, K.S.; Martin, N.P.; Dumont, M.E., 1999:
Dominant negative mutations in the alpha-factor receptor, a G protein-coupled receptor encoded by the STE2 gene of the yeast Saccharomyces cerevisiae

Zhu, X.; Hadhazy, M.; Wehling, M.; Tidball, J.G.; Mcnally, E.M., 2000:
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle

Izumi, T.; Yokota-Hashimoto, H.; Zhao, S.; Wang, J.; Halban, P.A.; Takeuchi, T., 2003:
Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse

Ikeda, Y.; Taniguchi, N.; Noguchi, T., 2000:
Dominant negative role of the glutamic acid residue conserved in the pyruvate kinase M(1) isozyme in the heterotropic allosteric effect involving fructose-1,6-bisphosphate

Clifford, J.L.; Yang, X.; Walch, E.; Wang, M.; Lippman, S.M., 2003:
Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells

Coady, M.A.; Mandapati, D.; Arunachalam, B.; Jensen, K.; Maher, S.E.; Bothwell, A.L.; Hammond, G.L., 1999:
Dominant negative suppression of major histocompatibility complex genes occurs in trophoblasts

Sutton, P.; Kolesnikow, T.; Danon, S.; Wilson, J.; Lee, A., 2000:
Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon

Johnston, R.L.; Seller, M.J.; Behnam, J.T.; Burdon, M.A.; Spalton, D.J., 1999:
Dominant optic atrophy. Refining the clinical diagnostic criteria in light of genetic linkage studies

Picard, F.; Baulac, S.; Kahane, P.; Hirsch, E.; Sebastianelli, R.; Thomas, P.; Vigevano, F.; Genton, P.; Guerrini, R.; Gericke, C.A.; An, I.; Rudolf, G.; Herman, A.; Brice, A.; Marescaux, C.; LeGuern, E., 2000:
Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families

Russell, K.L.; Ming, J.E.; Patel, K.; Jukofsky, L.; Magnusson, M.; Krantz, I.D., 2001:
Dominant paternal transmission of Cornelia de Lange syndrome: A new case and review of 25 previously reported familial recurrences

Trettel, F.; Rigamonti, D.; Hilditch-Maguire, P.; Wheeler, V.C.; Sharp, A.H.; Persichetti, F.; Cattaneo, E.; MacDonald, M.E., 2000:
Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells

Matsumoto, M.; Traboulsi, E.I., 2001:
Dominant radial drusen and Arg345Trp EFEMP1 mutation

Hussain, R.; Dockrell, H.M.; Chiang, T.J., 1999:
Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy

Cioffi, D.L.; Moore, T.M.; Schaack, J.; Creighton, J.R.; Cooper, D.M.F.; Stevens, T., 2002:
Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase

Honey, K.; Cobbold, S.P.; Waldmann, H., 1999:
Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Imao, T.; Koshida, K.; Endo, Y.; Uchibayashi, T.; Sasaki, T.; Namiki, M., 1999:
Dominant role of E-cadherin in the progression of bladder cancer

Martin, S.; van den Engel, N.K.; Vinke, A.; Heidenthal, E.; Schulte, B.; Kolb, H., 2001:
Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice

Ledvina, P.S.; Tsai, A.L.; Wang, Z.; Koehl, E.; Quiocho, F.A., 1998:
Dominant role of local dipolar interactions in phosphate binding to a receptor cleft with an electronegative charge surface: equilibrium, kinetic, and crystallographic studies

Bukovsky, A.; Caudle, M.R.; Keenan, J.A., 2000:
Dominant role of monocytes in control of tissue function and aging

Jolimay, N.; Franck, L.; Langlois, X.; Hamon, M.; Darmon, M., 2000:
Dominant role of the cytosolic C-terminal domain of the rat 5-HT1B receptor in axonal-apical targeting

Brown, L.R.; Deng, J.; Clarke, N.D., 2000:
Dominant sensitization variants of human O6-methylguanine-DNA-methyltransferase obtained by a mutational screen of surface residues

Naumenko, Y.V., 1998:
Dominant species of the phytoplancton of the Ob river

Skrzypek, M.; Lester, R.L.; Spielmann, P.; Zingg, N.; Shelling, J.; Dickson, R.C., 2000:
Dominant suppressor mutation bypasses the sphingolipid requirement for growth of Saccharomyces cells at low pH: Role of the CWP2 gene

Honey, K.; Cobbold, S.P.; Waldmann, H., 2000:
Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions

Stelling, J.R.; Gray, M.R.; Davis, A.J.; Cowan, J.M.; Reindollar, R.H., 2000:
Dominant transmission of imperforate hymen

Haberman, Juta, 2000:
Dominant zooplankton species in Lake Peipsi

Notidis, E.; Heltemes, L.; Manser, T., 2002:
Dominant, hierarchical induction of peripheral tolerance during foreign antigen-driven B cell development

Yeh, J.H.; Sun, M.H.; Chiu, H.C., 1999:
Dominant-inherited hypokalemic periodic paralysis in a large Chinese family

Anders, K.R.; Botstein, D., 2001:
Dominant-lethal alpha-tubulin mutants defective in microtubule depolymerization in yeast

Vizirianakis, I.S.; Chen, Y-Qi.; Kantak, S.S.; Tsiftsoglou, A.S.; Kramer, R.H., 2002:
Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells

Andreucci, A.; Reeves, R.; McCarthy, K.M.; Nikolajczyk, B.S., 2002:
Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism

Abbas, S.; Abu-Amer, Y., 2003 :
Dominant-negative IkappaB facilitates apoptosis of osteoclasts by tumor necrosis factor-alpha

Lee, Y., J.; Galoforo, S., S.; Sim, J., E.; Ridnour, L., A.; Choi, J.; Forman, H.-Jay; Corry, P., M.; Spitz, D., R., 2000:
Dominant-negative Jun N-terminal protein kinase (JNK-1) inhibits metabolic oxidative stress during glucose deprivation in a human breast carcinoma cell line

Stewart, B.A.; Mohtashami, M.; Rivlin, P.; Deitcher, D.L.; Trimble, W.S.; Boulianne, G.L., 2002:
Dominant-negative NSF2 disrupts the structure and function of Drosophila neuromuscular synapses

Akeda, Y.; Kodama, T.; Kashimoto, T.; Cantarelli, V.; Horiguchi, Y.; Nagayama, K.; Iida, T.; Honda, T., 2002:
Dominant-negative Rho, Rac, and Cdc42 facilitate the invasion process of Vibrio parahaemolyticus into Caco-2 cells

Hoodless, P.A.; Tsukazaki, T.; Nishimatsu, S.I.hiro; Attisano, L.; Wrana, J.L.; Thomsen, G.H., 1999:
Dominant-negative Smad2 mutants inhibit activin/Vg1 signaling and disrupt axis formation in Xenopus

Leaños-Miranda, A.; Ulloa-Aguirre, A.; Ji, T.H.; Janovick, J.Ann.; Conn, P.Michael., 2003:
Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans

Sylvain, V.; Lafarge, S.; Bignon, Y-Jean., 2002:
Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line

Chen, S.; Lin, F.; Xu, M.; Hwa, J.; Graham, R.M., 2000:
Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation

Roth, D.; Birkenfeld, J.; Betz, H., 1999:
Dominant-negative alleles of 14-3-3 proteins cause defects in actin organization and vesicle targeting in the yeast Saccharomyces cerevisiae

Whitfield, J.; Neame, S.J.; Paquet, L.; Bernard, O.; Ham, J., 2001:
Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release

Amorino, G.P.; Mikkelsen, R.B.; Valerie, K.; Schmidt-Ullrich, R.K., 2003:
Dominant-negative cAMP-responsive element-binding protein inhibits proliferating cell nuclear antigen and DNA repair, leading to increased cellular radiosensitivity

Kage, K.; Tsukahara, S.; Sugiyama, T.; Asada, S.; Ishikawa, E.; Tsuruo, T.; Sugimoto, Y., 2002:
Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization

Lee, A.; Frank, D.W.; Marks, M.S.; Lemmon, M.A., 1999:
Dominant-negative inhibition of receptor-mediated endocytosis by a dynamin-1 mutant with a defective pleckstrin homology domain

Belecz, I.; Gonzalez, C.; Puro, J.; Szabad, J., 2001:
Dominant-negative mutant dynein allows spontaneous centrosome assembly, uncouples chromosome and centrosome cycles

Shinotsuka, C.; Waguri, S.; Wakasugi, M.; Uchiyama, Y.; Nakayama, K., 2002:
Dominant-negative mutant of BIG2, an ARF-guanine nucleotide exchange factor, specifically affects membrane trafficking from the trans-Golgi network through inhibiting membrane association of AP-1 and GGA coat proteins

Bae, T.; Dunny, G.M., 2001:
Dominant-negative mutants of prgX: Evidence for a role for PrgX dimerization in negative regulation of pheromone-inducible conjugation

Schweisguth, F., 1999:
Dominant-negative mutation in the beta2 and beta6 proteasome subunit genes affect alternative cell fate decisions in the Drosophila sense organ lineage

Sakuragi, N.; Hirai, A.; Tada, M.; Yamada, H.; Yamamoto, R.; Fujimoto, S.; Moriuchi, T., 2001 :
Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma

Marutani, M.; Tonoki, H.; Tada, M.; Takahashi, M.; Kashiwazaki, H.; Hida, Y.; Hamada, J.; Asaka, M.; Moriuchi, T., 1999:
Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme

Morrison, A.J.; Herrera, R.E.; Heinsohn, E.Coronado.; Schiff, R.; Osborne, C.Kent., 2003:
Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor

Han, Z.; Boyle, D.L.; Shi, Y.; Green, D.R.; Firestein, G.S., 1999:
Dominant-negative p53 mutations in rheumatoid arthritis

Er, F.; Larbig, R.; Ludwig, A.; Biel, M.; Hofmann, F.; Beuckelmann, D.J.; Hoppe, U.C., 2003:
Dominant-negative suppression of HCN channels markedly reduces the native pacemaker current I(f) and undermines spontaneous beating of neonatal cardiomyocytes

Xue, T.; Marbán, E.; Li, R.A., 2002:
Dominant-negative suppression of HCN1- and HCN2-encoded pacemaker currents by an engineered HCN1 construct: insights into structure-function relationships and multimerization

Mclerie, M.; Lopatin, A., 2003:
Dominant-negative suppression of IK1 in the mouse heart leads to altered cardiac excitability

Raghib, A.; Bertaso, F.; Davies, A.; Page, K.M.; Meir, A.; Bogdanov, Y.; Dolphin, A.C., 2001:
Dominant-negative synthesis suppression of voltage-gated calcium channel Cav2.2 induced by truncated constructs

Li, F.; Szobor, A.; Croxen, R.; Anselmo, V.; Yuan, Q.P.; Lindblad, K.; Schalling, M.; Komoly, S.; Beeson, D.; Larsson, C., 2001:
Dominantly inherited familial myasthenia gravis as a separate genetic entity without involvement of defined candidate gene loci

Huopio, H.; Reimann, F.; Ashfield, R.; Komulainen, J.; Lenko, H.L.; Rahier, J.; Vauhkonen, I.; Kere, J.; Laakso, M.; Ashcroft, F.; Otonkoski, T., 2000:
Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1

Mueller, H.D.; Vielhaber, S.; Brunn, A.; Schroeder, J.M.chael, 2001:
Dominantly inherited myopathy with novel tubular aggregates containing 1-21 tubulofilamentous structures

Vallat, J-Michel., 2003:
Dominantly inherited peripheral neuropathies

Spangfort, M.D.; Mirza, O.; Ipsen, H.; Van Neerven, R.J.Joost.; Gajhede, M.; Larsen, Jørgen.N., 2003:
Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis

Frisk, A.L.; Baumgaertner, W.; Groene, A., 1999:
Dominating interleukin-10 mRNA expression induction in cerebrospinal fluid cells of dogs with natural canine distemper virus induced demyelinating and non-demyelinating CNS lesions

Donckier, V.; E.N.kadi, I.; Closset, J.; Ickx, B.; Louis, H.; L.M.ine, O.; Bourgeois, N.; Adler, M.; Gelin, M., 2001:
Domino hepatic transplantation using the liver from a patient with primary hyperoxaluria

Nishizaki, T.; Kishikawa, K.; Yoshizumi, T.; Uchiyama, H.; Okano, S.; Ikegami, T.; Hashimoto, K.; Nomoto, K.; Shimada, M.; Yanaga, K.; Takenaka, K.; Sugimachi, K.; Ando, Y.; Ando, M., 2000:
Domino liver transplantation from a living related donor

Arjona, Oón.; Csákÿ, A.G.; Medel, Río.; Plumet, Jín., 2002:
Domino metathesis of 2-azanorbornenones: a new strategy for the enatioselective synthesis of 1-azabicyclic compounds

Noetzel, M.W.; Rauch, K.; Labahn, T.; D.M.ijere, A., 2002:
Domino reactions of amidines with methyl 2-chloro-2-cyclopropylideneacetate as an efficient access to cyclobutene-annelated pyrimidinones

Macphee, R.; Iturralde Vinent, M.; Gaffney, E.S., 2003:
Domo de Zaza, an Early Miocene vertebrate locality in south-central Cuba, with notes on the tectonic evolution of Puerto Rico and the Mona Passage

Vale, P.; Sampayo, M., 2001:
Domoic acid in Portuguese shellfish and fish

Lefebvre, K.; Silver, M.; Coale, S.; Tjeerdema, R., 2002:
Domoic acid in planktivorous fish in relation to toxic Pseudo-nitzschia cell densities

Cheng, Z.; Guo, S.Z.; Lipton, A.J.; Gozal, D., 2002:
Domoic acid lesions in nucleus of the solitary tract: time-dependent recovery of hypoxic ventilatory response and peripheral afferent axonal plasticity

Berman, F.W.; Lepage, K.T.; Murray, T.F., 2002:
Domoic acid neurotoxicity in cultured cerebellar granule neurons is controlled preferentially by the NMDA receptor Ca2+ influx pathway

Kotaki, Yuichi; Koike, Kazuhiko; Yoshida, Makoto; Thuoc, Chu-Van; Huyen, Nguyen-Thi-Minh; Hoi, Nguyen-Chu; Fukuyo, Yasuwo; Kodama, Masaaki, 2000:
Domoic acid production in Nitzschia sp. (Bacillariophyceae) isolated from a shrimp-culture pond in Do Son, Vietnam

Trainer, V.L.; Adams, N.G.; Bill, B.D.; Stehr, C.M.; Wekell, J.C.; Moeller, P.; Busman, M.; Woodruff, D., 2000:
Domoic acid production near California coastal upwelling zones, June 1998

Sari, P.; Kerr, D.S.even, 2001:
Domoic acid-induced hippocampal CA1 hyperexcitability independent of region CA3 activity

Nijjar, M.S.; Nijjar, S.S., 2000:
Domoic acid-induced neurodegeneration resulting in memory loss is mediated by Ca2+ overload and inhibition of Ca2+ + calmodulin-stimulated adenylate cyclase in rat brain (review)

Ananth, C.; Dheen, S.T.ameem; Gopalakrishnakone, P.; Kaur, C., 2001:
Domoic acid-induced neuronal damage in the rat hippocampus: Changes in apoptosis related genes (Bcl-2, Bax, Caspase-3) and microglial response

Mos, Lizzy, 2001:
Domoic acid: A fascinating marine toxin

Franzese, A.; Borrelli, O.; Corrado, G.; Rea, P.; D.N.rdo, G.; Grandinetti, A.L.; Dito, L.; Cucchiara, S., 2002:
Domperidone is more effective than cisapride in children with diabetic gastroparesis

Drolet, B.; Rousseau, G.; Daleau, P.; Cardinal, R.; Turgeon, J., 2000:
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders

Wang, D.S.ou; Lin Hao Ran; P.D.Y.ng; Zhang Yao Guang; Zhang, Q.Z.ong; H.X.e Fu; Jiang Guo Fu, 1998:
Domperidone-LHRH-A-induced ovulation of the bagrid catfish, Mystus macropterus and Leiocassis longirostris

Barone, Joseph, A., 1999:
Domperidone: A peripherally acting dopamine2-receptor antagonist

Brodsky, S.L.; Lichtenstein, B., 1999:
Don't ask questions: a psychotherapeutic strategy for treatment of involuntary clients

Ubel, P.A.; Jepson, C.; Silver Isenstadt, A., 2003:
Don't ask, don't tell: A change in medical student attitudes after obstetrics/gynecology clerkships toward seeking consent for pelvic examinations on an anesthetized patient

Menke, D.; Fiedler, H.; Zwahr, H., 2003:
Don't ban PVC: incinerate and recycle it instead!

Evans, D.E.an; Sheehan, M., C., 2002:
Don't be fobbed off: The substance of beer foam: A review

Hart, R.; Magos, A.; Nagele, F.; Heal, K.; Isorna, V.; Jirecek, S.; Kudielka, I., 2004:
'Don't be fooled by the patient's make-up'!

Field, S.A.; Calbert, G., 1999:
Don't count your eggs before they're parasitized: Contest resolution and the trade-offs during patch defense in a parasitoid wasp

Goldmeier, D.; Greene, L., 2002:
Don't forget syphilis. Access to services for genitourinary medicine needs to be made easier

Clark, P.; Cook, P.A.; Lighton, L.; Syed, Q.; Bellis, M.A., 2002:
Don't forget syphilis. Syphilis outbreak is twice as big as reported

Remer, T.; Manz, F., 2001:
Don't forget the acid base status when studying metabolic and clinical effects of dietary potassium depletion

Logan, G.D.; Irwin, D.E., 2000:
Don't look! Don't touch! Inhibitory control of eye and hand movements

Mehta, A.C., 2002:
Don't lose the forest for the trees: satisfaction and success in bronchoscopy

Newble, D.I., 2002:
Don't presume about experienced adult learners in medicine

Al-Shahi, R.; Kennard, C., 2002:
Don't slip through the net

Keswani, S.C.; Wityk, R., 2002:
Don't throw in the towelEPSILONXC A case of reversible coma

Baselga, A.; Novoa, F., 2002:
Donacia galaica Baguena, 1959, a little known species from Northwest of the Iberic peninsula (Coleoptera, Chrysomelidae)

Martin, Aés.; Cohen, D.J., 2002:
Donald J. Cohen, M.D., 1940-2001

Hoff, Julian, T., 2003:
Donald J. Reis, MD: Research mentor extraordinaire

Talman, William, T., 2001:
Donald Jeffrey Reis, MD: September 9, 1931-November 1, 2000

Gruber, Samuel, H., 2001:
Donald Richard Nelson: The most unforgettable character I ever met

Zhang, D.Y.ng; Sun, G.J.n; Jiang, X.H.a, 1999:
Donald's ideotype and growth redundancy: A game theoretical analysis

Luna-Zaragoza, D.; Reyes-Frías, M.L., 2004:
Donation transplants and tissue banking in Mexico

Medendorp, W.P.; van Gisbergen, J.A.; Horstink, M.W.; Gielen, C.C., 1999:
Donders' law in torticollis

Yesavage, J.A.; Mumenthaler, M.S.; Taylor, J.L.; Friedman, L.; O'Hara, R.; Sheikh, J.; Tinklenberg, J.; Whitehouse, P.J., 2002:
Donepezil and flight simulator performance: effects on retention of complex skills

Wolfson, C.; Oremus, M.; Shukla, V.; Momoli, F.; Demers, L.; Perrault, A.; Moride, Y., 2002:
Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness

Bergman, J.; Brettholz, I.; Shneidman, M.; Lerner, V., 2003:
Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's type

Kasa, P.; Papp, H.; Kasa, P.Jr.; Torok, I., 2000:
Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain

Kishnani, P.S.; Spiridigliozzi, G.A.; Heller, J.H.; Sullivan, J.A.; Doraiswamy, P.M.; Krishnan, K.R., 2001:
Donepezil for Down's syndrome

Noyan, M.A.sin; Elbi, H.; Aksu, H., 2003:
Donepezil for anticholinergic drug intoxication: A case report

Lanctot, K.L.; Herrmann, N., 2000:
Donepezil for behavioural disorders associated with Lewy bodies: A case series

Aarsland, D.; Laake, K.; Larsen, J.P.; Janvin, C., 2002:
Donepezil for cognitive impairment in Parkinson's disease: A randomised controlled study

Howard, A.K.; Thornton, A.E.; Altman, S.; Honer, W.G., 2002:
Donepezil for memory dysfunction in schizophrenia

Jacobsen, F.M.; Comas-Díaz, L., 1999:
Donepezil for psychotropic-induced memory loss

Barak, Y.; Bodner, E.; Zemishlani, H.; Mirecki, I.; Aizenberg, D., 2001:
Donepezil for the treatment of behavioral disturbances in Alzheimer's disease: A 6-month open trial

Paleacu, D.; Mazeh, D.; Mirecki, I.; Even, M.; Barak, Y., 2002:
Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease

Heller, J.H.; Spiridigliozzi, G.A.; Sullivan, J.A.; Doraiswamy, P.Murali.; Krishnan, R.R.; Kishnani, P.S., 2002:
Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial

Nakano, S.; Asada, T.; Matsuda, H.; Uno, M.; Takasaki, M., 2001:
Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease

Matthews, H.P.; Korbey, J.; Wilkinson, D.G.; Rowden, J., 2000:
Donepezil in Alzheimer's disease: Eighteen month results from Southampton memory clinic

Macewan, G.W.; Ehmann, T.S.; Khanbhai, I.; Wrixon, C., 2001:
Donepezil in schizophrenia: Is it helpful? An experimental design case study

Rocca, P.; Cocuzza, E.; Marchiaro, L.; Bogetto, F., 2002:
Donepezil in the treatment of Alzheimer's disease: Long-term efficacy and safety

Fabbrini, G.; Barbanti, P.; Aurilia, C.; Pauletti, C.; Lenzi, G.L.; Meco, G., 2002:
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease

Fabbrini, G.; Barbanti, P.; Bonifati, V.; Colosimo, C.; Gasparini, M.; Vanacore, N.; Meco, G., 2001:
Donepezil in the treatment of progressive supranuclear palsy

Burt, T.; Sachs, G.S.; Demopulos, C., 1999:
Donepezil in treatment-resistant bipolar disorder

Wilkinson, D.; Doody, R.; Helme, R.; Taubman, K.; Mintzer, J.; Kertesz, A.; Pratt, R.D., 2003:
Donepezil in vascular dementia: a randomized, placebo-controlled study

Geldmacher, D.S.; Provenzano, G.; Mcrae, T.; Mastey, V.; Ieni, J.R., 2003:
Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease

Stryjer, R.; Bar, F.; Strous, R.D.; Baruch, Y.; Rabey, J.Martin., 2002:
Donepezil management of schizophrenia with associated dementia

Shepherd, G.; Klein Schwartz, W.; Edwards, R., 1999:
Donepezil overdose: A tenfold dosing error

Higgins, G.A.; Enderlin, M.; Fimbel, R.; Haman, M.; Grottick, A.J.; Soriano, M.; Richards, J.G.; Kemp, J.A.; Gill, R., 2002:
Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia

Greenberg, S.M.; Tennis, M.K.; Brown, L.B.; Gomez-Isla, T.; Hayden, D.L.; Schoenfeld, D.A.; Walsh, K.L.; Corwin, C.; Daffner, K.R.; Friedman, P.; Meadows, M.E.; Sperling, R.A.; Growdon, J.H., 2000:
Donepezil therapy in clinical practice: a randomized crossover study

Onofrj, M.; Thomas, A.; Luciano, A.Lisa.; Iacono, D.; D.R.llo, A.; D'Andreamatteo, G.; D.I.rio, A., 2002:
Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease

Ogura, H.; Kosasa, T.; Kuriya, Y.; Yamanishi, Y., 2000:
Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats

Thomas, A.; Iacono, D.; Bonanni, L.; D'Andreamatteo, G.; Onofrj, M., 2001 :
Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months

Schredl, M.; Weber, B.; Leins, M.L.; Heuser, I., 2001:
Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons

Poletaev, V.I., 2000:
Donispirifer and Tegulispirifer: New Middle to Late Carboniferous spiriferids from Eurasia

Letienne, R.; Verscheure, Y.; Perez, M.; Le Grand, B.; Colpaert, F.C.; John, G.W., 2003:
Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig: further insights into its mechanism of action relevant to headache relief

Kleist, G.; Seehann, G., 1999:
Donkioporia expansa - A lesser known wood destroyer in buildings

Chassaing, N.; Lacombe, D.; Carles, D.; Calvas, P.; Saura, R.; Bieth, E., 2003:
Donnai-Barrow syndrome: four additional patients

Mougin, J.L.; Mougin, M.C., 2000:
Donnees complementaires sur la plongee du Puffin cendre Calonectris diomedea de Selvagem Grande (30degree 09' N, 15degree 52' W)

Essalmani, R.; Soulier, S.; Besnard, N.; Hudrisier, M.; Costa-Da-Silva, J.; Vilotte, J.L., 2000:
Donnees de base sur la transgenese

Fruchart, J.C.; Duriez, P., 2001:
Donnees fondamentales sur l'atherosclerose

Jorda, M.; Rosique, T.; Evin, J., 2000:
Donnees nouvelles sur l'age du dernier maximum glaciaire dans les Alpes meridionales francaises

Selmi, Slaheddine, 2000:
Donnees nouvelles sur les avifaunes des Oasis du Sud Tunisien

Brustel, H.; Freeman, J.-Cyril; Valladares, L.; Van-Meer, C., 2001:
Donnees originales sur quelques Cerambycidae des Pyrenees et regions voisines (Coleoptera)

Badih, A.; Pascual, F., 1998:
Donnees preliminaires sur les Celiferes du nord du Maroc (Orthoptera, Caelifera)

Moulard, B.; Crespel, A.; Malafosse, A.; Baldy-Moulinier, M., 2000:
Donnees recentes sur la genetique des epilepsies idiopathiques et des convulsions febriles

Duyckaerts, C.; Verny, M.; Hauw, J.J., 2003:
Donnees recentes sur la neuropathologie des syndromes parkinsoniens

Duchateau, S.; Bounine, E.; Delage, F., 2003:
Donnees sur le comportement de l'elanion blanc Elanus caeruleus en periode de reproduction en Aquitaine (France)

Asselbergs, Jan, E.F., 2000:
Donnees sur les captures recentes dans le sud-ouest de l'Europe de Pseudacrobasis nankingella Roesler, 1975, phycite originaire de l'Extreme-Orient (Lepidoptera, Pyralidae, Phycitinae)

Villard, P.; Thibault, J.C.aude, 2001:
Donnees sur les nids, la croissance des poussins et les soins parentaux chez la Sittelle corse Sitta whiteheadi

Montuschi, Olivia, 2002:
Donor Conception Network always advises openness

Beige, J.; Engeli, S.; Ringel, J.; Offermann, G.; Distler, A.; Sharma, A.M., 1999:
Donor G protein beta3 subunit 825TT genotype is associated with reduced kidney allograft survival

Shi, C.; Feinberg, M.W.; Zhang, D.; Patel, A.; Sim, C.U.; Dong, Z.M.; Chapman, S.M.; Gutierrez-Ramos, J.C.; Wagner, D.D.; Sibinga, N.E.; Haber, E., 1999:
Donor MHC and adhesion molecules in transplant arteriosclerosis

Benza, R.L.; Anderson, P.G.; Lyle, K.; Barchue, J.; D.O.iveira, A.L.na; Cavender, M.A.; Pinderski, L.J.; George, J.F., 2003:
Donor PAI-1 expression inhibits the intimal response of early allograft vascular disease

Zhang, Z.; Kaptanoglu, L.; Haddad, W.; Ivancic, D.; Alnadjim, Z.; Hurst, S.; Tishler, D.; Luster, A.D.; Barrett, T.A.; Fryer, J., 2002:
Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism

Hummel, S.; Wilms, D.; Vitacolonna, M.; Zöller, M., 2002:
Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host

Umemura, A.; Monaco, A.P.; Maki, T., 2000:
Donor T cells are not required for induction of allograft tolerance in mice treated with antilymphocyte serum, rapamycin, and donor bone marrow cells

Jiang, Z.; Podack, E.M.; Levy, R.B., 1998:
Donor T cells which cannot mediate perforin dependent and FasL-dependent cytotoxicity can effect graft vs. Host reactivity following allogeneic bone marrow transplantation

Lee, T.H.; Reed, W.; Mangawang-Montalvo, L.; Watson, J.; Busch, M.P., 2001:
Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility

Moreso, F.; Seron, D.; Gil Vernet, S.; Riera, L.; Fulladosa, X.; Ramos, R.; Alsina, J.; Grinyo, J.M.ria, 1999:
Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients

Newman, H.; Reems, J.Anna.; Rigley, T.H.; Bravo, D.; Strong, D.Michael., 2003:
Donor age and gender are the strongest predictors of marrow recovery from cadaveric vertebral bodies

Cohen, M.A.; Lindheim, S.R.; Sauer, M.V., 1999:
Donor age is paramount to success in oocyte donation

D.L.R.bia, J.; Diaz, M.A.; Verdeguer, A.; Pascual, M.J.; Arbona, C.; Arrieta, R.; Brunet, S.; Bargay, J.; Martinez, C.; Espigado, I.; Serrano, D.; Alegre, A.; D.A.riba, F.; D.L.S.rna, J.; Zamora, C.; Benlloch, L.; Sanz, M.A., 2001:
Donor age-related differences in PBPC mobilization with rHuG-CSF

Raisanen Sokolowski, A.; Glysing Jensen, T.; Russell, M.E., 1999:
Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: Insights from double knockout mice

Bakonyi, A.; Berho, M.; Ruiz, P.; Misiakos, E.P.; Carreno, M.; de Faria, W.; Sommariva, A.; Inverardi, L.; Miller, J.; Ricordi, C.; Tzakis, A.G., 2001:
Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model

Hareuveni, M.; Merchav, H.; Austerlitz, N.; Rahimi Leveen, N.; Ben Tal, O., 2002:
Donor anti-Jka causing hemolysis in a liver transplant recipient

Van der Hoeven, J.A.; Lindell, S.; van Schilfgaarde, R.; Molema, G.; Ter Horst, G.J.; Southard, J.H.; Ploeg, R.J., 2001:
Donor brain death reduces survival after transplantation in rat livers preserved for 20 hr

Qazi, Y.A.; Ali, Y.; Venuto, R.C., 2003:
Donor calculi induced acute renal failure

Vijay, P.; Scavo, V.A.; Morelock, R.J.; Sharp, T.G.; Brown, J.W., 1998:
Donor cardiac troponin T: A marker to predict heart transplant rejection

Schnuelle, P.; Lorenz, D.; Mueller, A.; Trede, M.; Van Der Woude, F.J., 1999:
Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation

Paglieroni, T.G.; Perez, R.; Katznelson, K.; Muto, K.; Chang, T.; Scott, S.; Mackenzie, M.R.; Holland, P.V., 1999:
Donor cell induced CD69 expression and intracellular IL-2 and IL-4 production by peripheral blood lymphocytes isolated from kidney transplant recipients

Cooley, L.D.; Sears, D.A.; Udden, M.M.; Harrison, W.R.; Baker, K.R., 2000:
Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature

Ehl, S.; Barchet, W.; Oehen, S.; Aichele, P.; Hombach, J.; Hengartner, H.; Zinkernagel, R.M., 2000:
Donor cell persistence and activation-induced unresponsiveness of peripheral CD8+ T cells

Barker, J.E.; Schuldt, A.J.T.; Lessard, M.D.; Jude, C.D.; Vogler, C.A.; Soper, B.W., 2003:
Donor cell replacement in mice transplanted in utero is limited by immune-independent mechanisms

Oback, Börn.; Wells, D., 2002:
Donor cells for nuclear cloning: many are called, but few are chosen

Kollman, C.; Howe, C.W.S.; Anasetti, C.; Antin, J.H.; Davies, S.M.; Filipovich, A.H.; Hegland, J.; Kamani, N.; Kernan, N.A.; King, R.; Ratanatharathorn, V.; Weisdorf, D.; Confer, D.L., 2001:
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age

Goebel, W.S.ott; Yoder, M.C.; Pech, N.K.; Dinauer, M.C., 2002:
Donor chimerism and stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: Effects of a retroviral-mediated gene transfer protocol and implications for gene therapy

Weill, D., 2002:
Donor criteria in lung transplantation: an issue revisited

Marshall, S.E.; McLaren, A.J.; McKinney, E.F.; Bird, T.G.; Haldar, N.A.; Bunce, M.; Morris, P.J.; Welsh, K.I., 2001:
Donor cytokine genotype influences the development of acute rejection after renal transplantation

O'Connell, P.J.; Burlingham, W.J., 1999:
Donor dendritic cell persistence in organ allograft recipients in the absence of immunosuppression

Nakagawa, K.; Matsuno, T.; Iwagaki, H.; Morimoto, Y.; Fujiwara, T.; Sadamori, H.; Inagaki, M.; Urushihara, N.; Yagi, T.; Tanaka, N., 2001:
Donor dendritic cells and recipient Kupffer cells in the induction of donor-specific immune hyporesponsiveness

Reinisch, W.; Lichtenberger, C.; Steger, G.; Tillinger, W.; Scheiner, O.; Gangl, A.; Maurer, D.; Willheim, M., 2003:
Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo

Buchta, C.; Bittner, C.; Hocker, P.; Macher, M.; Schmid, R.; Seger, C.; Dettke, M., 2003:
Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis

Fitzgerald, M.P.; Mollenhauer, J.; Brubaker, L., 2001:
Donor fascia in urogynaecological procedures: A canine model

Murata, S.I.; Kuśba, J.; Piszczek, G.; Gryczynski, I.; Lakowicz, J.R., 2000:
Donor fluorescence decay analysis for energy transfer in double-helical DNA with various acceptor concentrations

Hoenicke, E.M.; Peterseim, D.S.; Ducko, C.T.; Sun, X.; Damiano, R.J.Jr, 2000:
Donor heart preservation with the potassium channel opener pinacidil: Comparison with University of Wisconsin and St. Thomas' solution

Sakamoto, T.; Ye, Q.; Lu, L.; Demetris, A.J.; Starzl, T.E.; Murase, N., 1999:
Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts

Bucci, J.R.; Matsumoto, C.S.; Swanson, S.John.; Agodoa, L.Y.C.; Holtzmuller, K.C.; Peters, T.G.; Abbott, K.C., 2002:
Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation

Tan, H.P.; Samaniego, M.D.; Montgomery, R.A.; Burdick, J.F.; Maley, W.R.; Kraus, E.S.; Ratner, L.E., 2001:
Donor horseshoe kidneys for transplantation

Carmeli, Y.S.; Birenbaum-Carmeli, D.; Madgar, I.; Weissenberg, R., 2001:
Donor insemination in Israel. Recipients' choice of donor

Carmeli, Y.S.; Carmeli, D.B.; Matilsky YSM.K.lderon, I.; Yavetz, H., 2001:
Donor insemination in Israel: sociodemographic aspects

Cullup, H.; Dickinson, A.M.; Jackson, G.H.; Taylor, P.R.; Cavet, J.; Middleton, P.G., 2001:
Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants

Bijlsma, F.J.; Van Kuik, J.; Tilanus, M.G.J.; D.J.nge, N.; Rozemuller, E.H.; Van Den Tweel, J.G.; Gmelig Meyling, F.H.J.; D.W.ger, R.A., 2002:
Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation

Teshima, T.; Liu, C.; Lowler, K.P.; Dranoff, G.; Ferrara, J.L.M., 2002:
Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation

Vainikka, T.; Heikkilä, L.; Kukkonen, S.; Toivonen, H.; Verkkala, K.; Mattila, S., 1999:
Donor lung pretreatment with prostaglandin E(1) does not improve lung graft preservation

Kroeger, N.; Krueger, W.; Renges, H.; Zabelina, T.; Stute, N.; Jung, R.; Wittkowsky, G.; Kuse, R.; Zander, A.R.lf, 2001:
Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma

Leda, M.; Ladon, D.; Pieczonka, A.; Boruczkowski, D.; Jólkowska, J.; Witt, M.; Wachowiak, J., 2001:
Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

D.R.sa, G.; Pezzullo, L.; Scarpato, N.; Selleri, C.; Lucania, A.; Rotoli, B., 2000:
Donor lymphocyte infusion for post-transplant relapse of Hodgkin's lymphoma

Guglielmi, C.; Arcese, W.; Dazzi, F.; Brand, R.; Bunjes, D.; Verdonck, L.F.; Schattenberg, A.; Kolb, H-Jochem.; Ljungman, P.; Devergie, A.; Bacigalupo, A.; Gomez, M.; Michallet, M.; Elmaagacli, A.; Gratwohl, A.; Apperley, J.; Niederwieser, D., 2002:
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

Baron, F.; Dresse, M.F.ancoise; Beguin, Y., 2000:
Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease

Mapara, M.Y.; Kim, Y-Mi.; Marx, J.; Sykes, M., 2003:
Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism

Owaidah, T.M., 2003:
Donor lymphocyte infusion. An adaptive cellular immunotherapy for treatment of hematological malignancies

Dazzi, F.; Szydlo, R.M.; Goldman, J.M., 1999:
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand

Lokhorst, H.M.; Schattenberg, A.; Cornelissen, J.J.; van Oers, M.H.; Fibbe, W.; Russell, I.; Donk, N.W.; Verdonck, L.F., 2000:
Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

Riera, L.; Koziner, B., 2000:
Donor lymphocyte infusions for the treatment of relapse after allogeneic hematopoietic stem cell transplantation

Mapara, M.Y.; Kim, Y-Mi.; Wang, S-Ping.; Bronson, R.; Sachs, D.H.; Sykes, M., 2002:
Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

Flesland, O.; Pfeffer, P.F.; Solheim, B.G.; Mellbye, O.J., 2003:
Donor lymphocytes transferred with the graft to kidney recipients. Potential for establishing microchimerism

Delgado, D.H.; Rao, V.; Ross, H.J., 2002:
Donor management in cardiac transplantation

Western, K.H.; Videm, V., 2000:
Donor neutrophil function after plateletpheresis

Opsahl, M.S.; Thorsell, L.P.; Geltinger, M.E.; Iwaszko, M.A.; Blauer, K.L.; Sherins, R.J., 2002:
Donor oocyte cytoplasmic transfer did not enhance implantation of embryos of women with poor ovarian reserve

Fall, A.J.; Aitchison, J.D.; Krause, A.; Hasan, A.; Hamilton, J.R.; Gould, F.K., 2000:
Donor organ transmission of varicella zoster due to cardiac transplantation

Baehner, R.; Magrane, G.; Balassanian, R.; Chang, C.; Millward, C.; Wakil, A.E.; Osorio, R.W.; Waldman, F.M., 2000 :
Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics

Benson, S.R.C.; Ready, A.R.; Savage, C.O.S., 2002:
Donor platelet and leukocyte load identify renal allografts at an increased risk of acute rejection

Felleiter, P.; Freudenberg, J.; Wiesneth, M.; Kubanek, B., 1999:
Donor reactions and traffic risks in autologous blood predeposits

Shimoyama, R.; Nakase, T.; Kojima, S.; Tanaka, S.; Yamamori, K.; Kaneko, C.; Ishimaru, K.; Ikeda, H., 2002:
Donor selection in Japan: A trial of new criteria with predonation haemoglobin testing

Chen, C.D.; Helfman, D.M., 1999:
Donor site competition is involved in the regulation of alternative splicing of the rat beta-tropomyosin pre-mRNA

Silber, J.S.; Anderson, D.Greg.; Daffner, S.D.; Brislin, B.T.; Leland, J.Martin.; Hilibrand, A.S.; Vaccaro, A.R.; Albert, T.J., 2003:
Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion

Tang, C.L.; Mahoney, J.L.; Mckee, M.D.; Richards, R.R.; Waddell, J.P.; Louie, B.; Yoo, D., 1998:
Donor site morbidity following vascularized fibular grafting

Im, S.; Lee, E.So.; Kim, W.; On, W.; Kim, J.; Lee, M.; Kang, W.Hyoung., 2002:
Donor specific response of estrogen and progesterone on cultured human melanocytes

Pulai, J., I.; Zakeri, H.; Kwok, P.-Yan; Kim, J.-Ho; Wu, J.; Schonfeld, G., 1998:
Donor splice mutation (665 + 1 G-T) in familial hypobetalipoproteinemia with no detectable apoB truncation

Welty, F.K.; Guida, K.A.; Andersen, J.J., 2001:
Donor splice-site mutation (210+1G_C) in the ApoB gene causes a very low level of ApoB-100 and LDL cholesterol

Yamani, M.H.; Starling, R.C.; Cook, D.J.; Tuzcu, E.Murat.; Abdo, A.; Paul, P.; Powell, K.; Ratliff, N.B.; Yu, Y.; McCarthy, P.M.; Young, J.B., 2003:
Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient

Bubnic, S.J.; Keating, A., 2002:
Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation

Zavialov, A.V.; Kersley, J.; Korpela, T.; Zav'yalov, V.P.; Macintyre, S.; Knight, S.D., 2002:
Donor strand complementation mechanism in the biogenesis of non-pilus systems

Goan, S.R.; Junghahn, I.; Wissler, M.; Becker, M.; Aumann, J.; Just, U.; Martiny-Baron, G.; Fichtner, I.; Henschler, R., 2000:
Donor stromal cells from human blood engraft in NOD/SCID mice

Shao, J.; Zhang, J.; Kowal, P.; Wang, P.George., 2002:
Donor substrate regeneration for efficient synthesis of globotetraose and isoglobotetraose

Seto, N.O.L.; Compston, C.A.; Evans, S.V.; Bundle, D.R.; Narang, S.A.; Palcic, M.M., 1999:
Donor substrate specificity of recombinant human blood group A, B and hybrid A/B glycosyltransferases expressed in Escherichia coli

Gourishankar, S.; Jhangri, G.S.; Cockfield, S.M.; Halloran, P.F., 2003:
Donor tissue characteristics influence cadaver kidney transplant function and graft survival but not rejection

Valentin, J.F.; Bruijn, J.A.; Paul, L.C., 2000:
Donor treatment with mycophenolate mofetil: protection against ischemia-reperfusion injury in the rat

Polyak, M.M.; Arrington, B.O.; Kapur, S.; Stubenbord, W.T.; Kinkhabwala, M., 2000:
Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function

Phinney, D.G.; Kopen, G.; Righter, W.; Webster, S.; Tremain, N.; Prockop, D.J., 1999:
Donor variation in the growth properties and osteogenic potential of human marrow stromal cells

Sabbe, R.; Picchio, G.R.; Pastore, C.; Chaloin, O.; Hartley, O.; Offord, R.; Mosier, D.E., 2001:
Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression

Karpov, E.A.; Gladun, I.V.; Belozerova, O.L.; Odinokova, N.A., 1999:
Donor-acceptor interaction between buckwheat organs at the period of forming of fruit under the influence of growing regulator

D.S.yza, A.G.; Dark, J.H.; Parums, D.V.; Curtis, A.; Corris, P.A., 2001:
Donor-acquired small cell lung cancer following pulmonary transplantation

Haltrich, I.; Muller, J.; Szabo, J.; Kovacs, G.; Koos, R.; Poros, A.; Dobos, M.; Fekete, G., 2003:
Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia

Hancock, W.W.; Gao, W.; Csizmadia, V.; Faia, K.L.; Shemmeri, N.; Luster, A.D., 2001:
Donor-derived IP-10 initiates development of acute allograft rejection

Seltsam, A.; Hell, A.; Heymann, G.; Salama, A., 2001:
Donor-derived alloantibodies and passenger lymphocyte syndrome in two of four patients who received different organs from the same donor

Crough, T.; Nieda, M.; Morton, J.; Bashford, J.; Durrant, S.; Nicol, A.J., 2002:
Donor-derived b2a2-specific T cells for immunotherapy of patients with chronic myeloid leukemia

Popa, E.R.; Kas-Deelen, A.M.; Hepkema, B.G.; Van Son, W.J.; The, T.Hauw.; Harmsen, M.C., 2002:
Donor-derived circulating endothelial cells after kidney transplantation

Rifle, Gérard.; Mousson, C., 2003:
Donor-derived hematopoietic cells in organ transplantation: a major step toward allograft tolerance?

Hervé, P., 2003:
Donor-derived hematopoietic stem cells in organ transplantation: technical aspects and hurdles yet to be cleared

Yang, Y.G.; Dey, B.R.; Sergio, J.J.; Pearson, D.A.; Sykes, M., 1998:
Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12

Yang, Y-Guang.; Qi, J.; Wang, M-Guang.; Sykes, M., 2002:
Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells

Bodvarsson, S.; Burlingham, W.; Kusaka, S.; Hafez, G.R.za; Becker, B.N.; Pintar, T.; Sollinger, H.W.; Albertini, M.R., 2001:
Donor-derived small cell lung carcinoma in a kidney transplant recipient

Lu, H.F.; Shekarriz, B.; Stoller, M.L., 2002:
Donor-gifted allograft urolithiasis: Early percutaneous management

Young, K.J.; Yang, L.; Phillips, M.James.; Zhang, L., 2002:
Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells

Balduini, C.L.; Frassoni, F.; Noris, P.; Klersy, C.; Iannone, A.M.; Bacigalupo, A.; Giorgiani, G.; D.P.mpo, M.; Locatelli, F., 2001:
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor

Clave, E.; Molldrem, J.; Hensel, N.; Raptis, A.; Barrett, A.J., 1999:
Donor-recipient polymorphism of the proteinase 3 gene: a potential target for T-cell alloresponses to myeloid leukemia

Cotler, S.J.; Gaur, L.K.; Gretch, D.R.; Wile, M.; Strong, D.M.; Bronner, M.P.; Carithers, R.L.Jr.; Emond, M.J.; Perkins, J.D.; Nelson, K.A., 1998:
Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation

Kartus, J.; Movin, T.; Karlsson, J., 2001:
Donor-site morbidity and anterior knee problems after anterior cruciate ligament reconstruction using autografts

van Besouw, N.M.; van der Mast, B.J.; de Kuiper, P.; Smak Gregoor, P.J.; Vaessen, L.M.; IJzermans, J.N.; van Gelder, T.; Weimar, W., 2000:
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced

Margenthaler, J.A.; Kataoka, M.; Flye, M.Wayne., 2003:
Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells

Inuzuka, S.; Koga, S.; Nishikido, M.; Miyata, Y.; Kanda, S.; Shimokawa, I.; Tanaka, M.; Saito, Y.; Kanetake, H., 2002:
Donor-specific blood transfusion prolongs cardiac allograft survival in rats by low nitric oxide production and elevated serum levels of prostaglandin E2

Landolina, M.; D.F.rrari, G.M.; Cantu, F.; Campana, C., 2000:
Donor-to-recipient decremental conduction of atrial fibrillation following orthotopic heart transplantation: Insights into the mechanism of atrioatrial conduction

Burket, J.S.; Chenoweth, C.E.; Meyer, T.L.; Barg, N.L., 1999:
Donor-to-recipient transmission of bacteria as an unusual cause of mediastinitis in a heart transplant recipient

Grauhan, O.; Patzurek, J.; Hummel, M.; Lehmkuhl, H.; Dandel, M.; Pasic, M.; Weng, Y.; Hetzer, R., 2003:
Donor-transmitted coronary atherosclerosis

Hoffmann, P.; Ermann, J.; Edinger, M.; Fathman, C.G.rrison; Strober, S., 2002:
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

Zhao, Y.; Lan, F.; Gan, J.; Yao, X.; Reisner, Y., 1999:
Donor-type chimerism determination by competitive polymerase chain reaction (PCR) in a primate model for bone marrow transplantation

Hurley, D.J.; Tor, Y., 2002:
Donor/acceptor interactions in systematically modified Ru(II)-Os(II) oligonucleotides

Karu, T.I.; Pyatibrat, L.V.; Kalendo, G.S., 2001:
Donors of NO and pulsed radiation at lambda = 820 nm exert effects on cell attachment to extracellular matrices

Wilson, D.J.; Fisher, A.; Das, K.; Goerlitz, F.; Holland, B.K.; De La Torre, A.N.; Merchant, A.; Seguel, J.; Samanta, A.K.; Koneru, B., 2003:
Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts

Buell, J.F.; Trofe, J.; Sethuraman, G.; Hanaway, M.J.; Beebe, T.M.; Gross, T.G.; Alloway, R.; First, M.Roy.; Woodle, E.Steve., 2003:
Donors with central nervous system malignancies: are they truly safe?

O'farrell, Nigel, 2001:
Donovanosis: An update

Denes, G.; Signorini, M., 2001:
Door but not four and 4 a category specific transcoding deficit in a pure acalculic patient

Rocca, W.A.; Savettieri, G.; Anderson, D.W.; Meneghini, F.; Grigoletto, F.; Morgante, L.; Reggio, A.; Salemi, G.; Patti, F.; Di Perri, R., 2001:
Door-to-door prevalence survey of epilepsy in three Sicilian municipalities

Bertoldi, M.; Voltattorni, C.B., 2001:
Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine)

Hershey, T.; Black, K.J.; Carl, J.L.; Perlmutter, J.S., 2000:
Dopa-induced blood flow responses in nonhuman primates

Hida, H.; Hashimoto, M.; Fujimoto, I.; Nakajima, K.; Shimano, Y.; Nagatsu, T.; Mikoshiba, K.; Nishino, H., 1999:
Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: In vitro study and transplantation to hemiparkinsonian model rats

Romstad, A.; Dupont, E.; Krag-Olsen, B.; Østergaard, K.; Guldberg, P.; Güttler, F., 2003:
Dopa-responsive dystonia and Tourette syndrome in a large Danish family

Furukawa, Y.; Guttman, M.; Sparagana, S.P.; Trugman, J.M.; Hyland, K.; Wyatt, P.; Lang, A.E.; Rouleau, G.A.; Shimadzu, M.; Kish, S.J., 2000:
Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene

Hwu, W.L.ang; Wang, P.J.ng; Hsiao, K.J.n; Wang, T.R.n; Chiou, Y.W.i; Lee, Y.M.y, 1999:
Dopa-responsive dystonia induced by a recessive GTP cyclohydrolase I mutation

Hwu, W.L.ang; Chiou, Y.W.i; Lai, S.Y.; Lee, Y.M.y, 2000:
Dopa-responsive dystonia is induced by a dominant-negative mechanism

Furukawa, Y.; Graf, W.D.; Wong, H.; Shimadzu, M.; Kish, S.J., 2001:
Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations

Steinberger, D.; Korinthenberg, R.; Topka, H.; Berghaeuser, M.; Wedde, R.; Mueller, U., 2000:
Dopa-responsive dystonia: Mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa

Ebersbach, G.; Stoeck, M.; Mueller, J.; Wissel, J.; Poewe, W., 2000:
Dopa-responsive postural tremor in Parkinson's disease

Ama, P.F.M.; Ama, V.J.; Kamga, J.P.; Sato, G.; Laure, P., 2002:
Dopage et sport: Connaissances et attitudes des pharmaciens de la ville de Yaounde

Yamamoto, K.; Cubells, J.F.; Gelernter, J.; Benkelfat, C.; Lalonde, P.; Bloom, D.; Lal, S.; Labelle, A.; Turecki, G.; Rouleau, G.A.; Joober, R., 2003:
Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study

Soyka, M.; Preuss, U.W.; Koller, G.; Zill, P.; Bondy, B., 2002:
Dopamine D 4 receptor gene polymorphism and extraversion revisited: Results from the Munich gene bank project for alcoholism

Hanson, G.R.; Keefe, K.A., 1999:
Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway

Kerr, J.N.; Wickens, J.R., 2001:
Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro

Hersi, A.I.; Kitaichi, K.; Srivastava, L.K.; Gaudreau, P.; Quirion, R., 2000:
Dopamine D-5 receptor modulates hippocampal acetylcholine release

Black, K.J.; Hershey, T.; Gado, M.H.; Perlmutter, J.S., 2000:
Dopamine D(1) agonist activates temporal lobe structures in primates

Sugahara, M.; Shiraishi, H., 1999:
Dopamine D1 and D2 receptor agents and their interaction influence the synaptic density of the rat prefrontal cortex

Bahk, J.Y.; Li, S.; Park, M.S.; Kim, M.O., 2002:
Dopamine D1 and D2 receptor mRNA up-regulation in the caudate-putamen and nucleus accumbens of rat brains by smoking

Weed, M.R.; Woolverton, W.L.; Paul, I.A., 1998:
Dopamine D1 and D2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata

Ongali, B.; Ase, A.R.; Hébert, C.; Amdiss, F.; Reader, T.A., 2000:
Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents

Kimmel, H.L.; Joyce, A.R.; Carroll, F.I.; Kuhar, M.J., 2001:
Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat

Floresco, S.B.; Blaha, C.D.; Yang, C.R.; Phillips, A.G., 2001:
Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons

Hauber, W.; Lutz, S., 1999:
Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat

Sorg, B.A.; Li, N.; Wu, W.R., 2001:
Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization

D'aquila, P.S.; Panin, F.; Cossu, M.; Peana, A.T.; Serra, G., 2003:
Dopamine D1 receptor agonists induce penile erections in rats

Yao, L.P.; Li, X.X.; Yu, P.Y.; Xu, J.; Asico, L.D.; Jose, P.A., 1998:
Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats

Boksa, P.; Zhang, Y.; Bestawros, A., 2002:
Dopamine D1 receptor changes due to caesarean section birth: effects of anesthesia, developmental time course, and functional consequences

Hurley, M.J.; Mash, D.C.; Jenner, P., 2001:
Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease

Kojima, H.; Ohmori, O.; Shinkai, T.; Terao, T.; Suzuki, T.; Abe, K., 1999:
Dopamine D1 receptor gene polymorphism and schizophrenia in Japan

Sato, M.; Soma, M.; Nakayama, T.; Kanmatsuse, K., 2000:
Dopamine D1 receptor gene polymorphism is associated with essential hypertension

Grondin, R.; Goulet, M.; Morissette, M.; Bedard, P.J.; D.P.olo, T., 1999:
Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958

Rodriguez Puertas, R.; Herrera Marschitz, M.; Koistinaho, J.; Hokfelt, T., 1999:
Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats

Grider, J.S.; Ott, C.E.; Jackson, B.A., 2003:
Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: Mechanism of action

Dunah, A.W.; Standaert, D.G., 2001:
Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane

Svenningsson, P.; Fienberg, A.A.; Allen, P.B.; L.M.ine, C.; Lindskog, M.; Fisone, G.; Greengard, P.; Fredholm, B.B., 2000:
Dopamine D1 receptor-induced gene transcription is modulated by DARPP-32

Acquas, E.; D.C.iara, G., 1999:
Dopamine D1 receptor-mediated control of striatal acetylcholine release by endogenous dopamine

Schwienbacher, I.; Fendt, M.; Hauber, W.; Koch, M., 2002:
Dopamine D1 receptors and adenosine A1 receptors in the rat nucleus accumbens regulate motor activity but not prepulse inhibition

Mo, J.L.ng; Devos, P.; Trausch, G., 2002:
Dopamine D1 receptors in the gills of Chinese crab Eriocheir sinensis

Khroyan, T.V.; Barrett-Larimore, R.L.; Rowlett, J.K.; Spealman, R.D., 2000:
Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists

Dong, Y.; White, F.J., 2003:
Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons

Ricci, A.; Bronzetti, E.; Mignini, F.; Tayebati, S.K.osrow; Zaccheo, D.; Amenta, F., 1999:
Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes

Amenta, F.; Barili, P.; Bronzetti, E.; Ricci, A., 1999:
Dopamine D1-like receptor subtypes in the rat kidney: a microanatomical study

Mora Ferrer, C.; Yazulla, S.; Studholme, K.M.; Haak Frendscho, M., 1999:
Dopamine D1-receptor immunolocalization in goldfish retina

Tong, J.; Ross, B.M.; Sherwin, A.L.; Kish, S.J., 2001:
Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain

Svenningsson, P.; L.M.ine, C., 2002:
Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: Possible involvement of local D5 receptors

Gong, W.; Neill, D.B.; Lynn, M.; Justice, J.B.Jr, 1999:
Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site

Gorelova, N.A.; Yang, C.R., 2000:
Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro

Van Kampen, J.M.; Stoessl, A.J., 2000:
Dopamine D1A receptor function in a rodent model of tardive dyskinesia

Sugamori, K.S.; Scheideler, M.A.; Vernier, P.; Niznik, H.B., 1998:
Dopamine D1B receptor chimeras reveal modulation of partial agonist activity by carboxyl-terminal tail sequences

Wiesbeck, G.A.; Weijers, H-G.; Wodarz, N.; Herrmann, M.J.; Johann, M.; Keller, H.K.; Michel, T.M.; Böning, J., 2003:
Dopamine D2 (DAD2) and dopamine D3 (DAD3) receptor gene polymorphisms and treatment outcome in alcohol dependence

Wang, Y.; Xu, R.; Sasaoka, T.; Tonegawa, S.; Kung, M.P.; Sankoorikal, E.B., 2000:
Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions

Narkar, V.A.; Hussain, T.; Pedemonte, C.; Lokhandwala, M.F., 2001:
Dopamine D(2) receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells

Tsai, S-Jen.; Yu, Y.W-Y.; Lin, C-Hua.; Chen, T-Jui.; Chen, S-Ping.; Hong, C-Jee., 2002:
Dopamine D2 receptor and N-methyl-D-aspartate receptor 2B subunit genetic variants and intelligence

Carta, G.; Gessa, G.L.; Nava, F., 1999:
Dopamine D(2) receptor antagonists prevent delta(9)-tetrahydrocannabinol-induced antinociception in rats

Parsey, R.V.; Oquendo, M.A.; Zea Ponce, Y.; Rodenhiser, J.; Kegeles, L.S.; Pratap, M.; Cooper, T.B.; Van Heertum, R.; Mann, J.J.hn; Laruelle, M., 2001:
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression

Hagelberg, N.; Martikainen, I.K.; Mansikka, H.; Hinkka, S.; Nagren, K.; Hietala, J.; Scheinin, H.; Pertovaara, A., 2002:
Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity

Hitzemann, R.; Hitzemann, B.; Rivera, S.; Gatley, J.; Thanos, P.; Shou, L.L.S.ming; Williams, R.W., 2003:
Dopamine D2 receptor binding, Drd2 expression and the number of dopamine neurons in the BXD recombinant inbred series: Genetic relationships to alcohol and other drug associated phenotypes

Kapur, S.; Barsoum, S.C.; Seeman, P., 2000:
Dopamine D(2) receptor blockade by haloperidol. (3)H-raclopride reveals much higher occupancy than EEDQ

Bressan, R.A.; Jones, H.M.; Ell, P.J.; Pilowsky, L.S., 2001:
Dopamine D(2) receptor blockade in schizophrenia

Horvitz, J.C.; Eyny, Y.S., 2000:
Dopamine D2 receptor blockade reduces response likelihood but does not affect latency to emit a learned sensory-motor response: implications for Parkinson's disease

Armstrong, D.; Strange, P.G., 2001:
Dopamine D2 receptor dimer formation: evidence from ligand binding

Zawarynski, P.; Tallerico, T.; Seeman, P.; Lee, S.P.; O'dowd, B.F.; George, S.R., 1998:
Dopamine D2 receptor dimers in human and rat brain

Lu, R.-Band; Lee, J.-Fu; Ko, H.-Chen; Lin, W.-Wen, 2001:
Dopamine D2 receptor gene (DRD2) is associated with alcoholism with conduct disorder

Jönsson, E.G.; Sillén, A.; Vares, M.; Ekholm, B.; Terenius, L.; Sedvall, Göran.C., 2003:
Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis

Stefaneanu, L.; Kovacs, K.; Horvath, E.; Buchfelder, M.; Fahlbusch, R.; Lancranjan, I., 2001:
Dopamine D2 receptor gene expression in human adenohypophysial adenomas

Serretti, A.; Smeraldi, E., 1999:
Dopamine D2 receptor gene not associated with symptomatology of mood disorders

Oliveri, R.L.; Annesi, G.; Zappia, M.; Civitelli, D.; Montesanti, R.; Branca, D.; Nicoletti, G.; Spadafora, P.; Pasqua, A.A.; Cittadella, R.; Andreoli, V.; Gambardella, A.; Aguglia, U.; Quattrone, A., 1999:
Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD

Müller-Vahl, K.R.; Berding, G.; Kolbe, H.; Meyer, G.J.; Hundeshagen, H.; Dengler, R.; Knapp, W.H.; Emrich, H.M., 2000:
Dopamine D2 receptor imaging in Gilles de la Tourette syndrome

Yao, L.; Asai, K.; Jiang, Z.; Ishii, A.; Fan, P.; Gordon, A.S.; Diamond, I., 2001:
Dopamine D2 receptor inhibition of adenylyl cyclase is abolished by acute ethanol but restored after chronic ethanol exposure (tolerance)

Wolfe, S.E.; Morris, S.J., 1999:
Dopamine D2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels

Boulay, D.; Depoortere, R.; Perrault, G.; Borrelli, E.; Sanger, D.J., 1999:
Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists

Cooper, A.J.; Stanford, I.M., 2001:
Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABAA IPSCs in vitro

Lavalaye, J.; Linszen, D.H.; Booij, J.; Reneman, L.; Gersons, B.P.R.; Van Royen, E.A., 1999:
Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia

Wadenberg, M.L.; Soliman, A.; VanderSpek, S.C.; Kapur, S., 2001:
Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects

Wadenberg, M.L.; Kapur, S.; Soliman, A.; Jones, C.; Vaccarino, F., 2000:
Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats

Tallerico, T.; Ulpian, C.; Liu, I.S.C., 1999:
Dopamine D2 receptor promoter polymorphism: No association with schizophrenia

Pinborg, L., H.; Videbaek, C.; Knudsen, G., M.; Swahn, C.-Gunnar; Halldin, C.; Friberg, L.; Paulson, O., B.; Lassen, N., A., 2000:
Dopamine D2 receptor quantification in extrastriatal brain regions using (123I)epidepride with bolus/infusion

Salmi, P.; Sproat, B.S.; Ludwig, J.; Hale, R.; Avery, N.; Kela, J.; Wahlestedt, C., 2000:
Dopamine D2 receptor ribozyme inhibits quinpirole-induced stereotypy in rats

Bozzi, Y.; Borrelli, E., 2002 :
Dopamine D2 receptor signaling controls neuronal cell death induced by muscarinic and glutamatergic drugs

Dickinson, S.D.; Sabeti, J.; Larson, G.A.; Giardina, K.; Rubinstein, M.; Kelly, M.A.; Grandy, D.K.; Low, M.J.; Gerhardt, G.A.; Zahniser, N.R., 1999:
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum

Hellstrand, M.; Eriksson, E.; Nilsson, C.L., 2002:
Dopamine D2 receptor-induced COX-2-mediated production of prostaglandin E2 in D2-transfected Chinese hamster ovary cells without simultaneous administration of a Ca2+-mobilizing agent

Watts, V.J.; Taussig, R.; Neve, R.L.; Neve, K.A., 2001:
Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Galphas: characterization of Galphas-insensitive mutants of adenylyl cyclase V

Newman-Tancredi, A.; Cussac, D.; Brocco, M.; Rivet, J.-Michel; Chaput, C.; Touzard, M.; Pasteau, V.; Millan, M., J., 2001:
Dopamine D2 receptor-mediated G-protein activation in rat striatum: Functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra

IIda, M.; Miyazaki, I.; Tanaka, K.I.hi; Kabuto, H.; Iwata Ichikawa, E.; Ogawa, N., 1999:
Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist

Centonze, D.; Usiello, A.; Gubellini, P.; Pisani, A.; Borrelli, E.; Bernardi, G.; Calabresi, P., 2002:
Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors

Ennis, M.; Zhou, F.M.; Ciombor, K.J.; Aroniadou-Anderjaska, V.; Hayar, A.; Borrelli, E.; Zimmer, L.A.; Margolis, F.; Shipley, M.T., 2001:
Dopamine D2 receptor-mediated presynaptic inhibition of olfactory nerve terminals

Wang, Z.; Yu, G.; Cascio, C.; Liu, Y.; Gingrich, B.; Insel, T.R., 1999:
Dopamine D2 receptor-mediated regulation of partner preferences in female prairie voles (Microtus ochrogaster): a mechanism for pair bonding?

Sederholm, F.; Johnson, A.E.; Brodin, U.; Södersten, P., 2002:
Dopamine D(2) receptors and ingestive behavior: brainstem mediates inhibition of intraoral intake and accumbens mediates aversive taste behavior in male rats

Kapur, S.; Remington, G., 2001:
Dopamine D2 receptors and their role in atypical antipsychotic action: Still necessary and may even be sufficient

Tupala, E.; Hall, Håkan.; Bergström, K.; Mantere, T.; Räsänen, P.; Särkioja, T.; Tiihonen, J., 2003:
Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography

Wang, H.; Pickel, V.M., 2002:
Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus

Suhara, T.; Yasuno, F.; Sudo, Y.; Yamamoto, M.; Inoue, M.; Okubo, Y.; Suzuki, K., 2001:
Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking

Gingrich, B.; Liu, Y.; Cascio, C.; Wang, Z.; Insel, T.R., 2000:
Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtus ochrogaster)

Ko, F.; Seeman, P.; Sun, W.S.; Kapur, S., 2002:
Dopamine D2 receptors internalize in their low-affinity state

Lindgren, N.; Xu, Z.Q.ng David; Herrera Marschitz, M.; Haycock, J.; Kokfelt, T.; Fisone, G., 2001:
Dopamine D2 receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum

Levens, N.; Green, T., A.; Akins, C., K.; Bardo, M., T., 2000 :
Dopamine D2-like receptor binding in the brain of male Japanese quail (Coturnix japonica)

Luippold, G.; Schneider, S.; Stefanescu, A.; Benoehr, P.; Muehlbauer, B., 2001:
Dopamine D2-like receptors and amino acid-induced glomerular hyperfiltration in humans

Amenta, F.; Bronzetti, E.; Felici, L.; Ricci, A.; Tayebati, S.K., 1999:
Dopamine D2-like receptors on human peripheral blood lymphocytes: A radioligand binding assay and immunocytochemical study

Momiyama, T.; Koga, E., 2001:
Dopamine D2-like receptors selectively block N-type Ca2+ channels to reduce GABA release onto rat striatal cholinergic interneurones

Wolfe, S.E.; Howard, D.E.; Schetz, J.A.; Cheng, C.J.; Webber, R.; Beatty, D.M.; Chronwall, B.M.; Morris, S.J., 1999:
Dopamine D2-receptor isoforms expressed in AtT20 cells inhibit Q-type high-voltage-activated Ca2+ channels via a membrane-delimited pathway

Sinnott, R.S.; Mach, R.H.; Nader, M.A., 1999:
Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys

Smith, J.W.; Fetsko, L.A.; Xu, R.; Wang, Y., 2002:
Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning

Vukhac, K.L.; Sankoorikal, E.B.; Wang, Y., 2001:
Dopamine D2L receptor- and age-related reduction in offensive aggression

Honda, K.; Riehl, J.; Mignot, E.; Nishino, S., 1999:
Dopamine D3 agonists into the substratia nigra aggravates cataplexy but does not modify sleep

L.F.ll, B.; Schwartz, J.C.; Sokoloff, P., 2000:
Dopamine D3 receptor agents as potential new medications for drug addiction

Boulay, D.; Depoortere, R.; Rostene, W.; Perrault, G.; Sanger, D.J., 1999:
Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice

Vorel, S.R.; Ashby, C.R.; Paul, M.; Liu, X.; Hayes, R.; Hagan, J.J.; Middlemiss, D.N.; Stemp, G.; Gardner, E.L., 2002:
Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats

Boyce, J.M.; Risinger, F.O., 2002:
Dopamine D3 receptor antagonist effects on the motivational effects of ethanol

Tremblay, M.; Rouillard, C.; Lévesque, D., 1999:
Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain

Kaichi, Y.; Nonaka, R.; Hagino, Y.; Watanabe, M., 2000:
Dopamine D3 receptor binding by D3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography

Jönsson, E.G.; Flyckt, L.; Burgert, E.; Crocq, M-Antoine.; Forslund, K.; Mattila-Evenden, M.; Rylander, G.; Asberg, M.; Nimgaonkar, V.L.; Edman, G.; Bjerkenstedt, L.; Wiesel, F-Axel.; Sedvall, Göran.C., 2003:
Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis

Garcia-Barcelo, M.M.; Lam, L.C.W.; Ungvari, G.S.; Lam, V.K.L.; Tang, W.K., 2001:
Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

Serretti, A.; Lattuada, E.; Cusin, C.; Lilli, R.; Lorenzi, C.; Smeraldi, E., 1999:
Dopamine D3 receptor gene not associated with symptomatology of major psychoses

Thome, J.; Weijers, H.G.; Wiesbeck, G.A.; Sian, J.; Nara, K.; Böning, J.; Riederer, P., 1999:
Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating

Scharfetter, J.; Chaudhry, H.R.; Hornik, K.; Fuchs, K.; Sieghart, W.; Kasper, S.; Aschauer, H.N., 1999:
Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients

Retz, W.; Rösler, M.; Supprian, T.; Retz-Junginger, P.; Thome, J., 2003:
Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology

Gurevich, E.V.; Joyce, J.N., 2000:
Dopamine D3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat

Boyce Rustay, J.M.; Risinger, F.O., 2003:
Dopamine D3 receptor knockout mice and the motivational effects of ethanol

Gyertyán, Ián.; Gál, K., 2003:
Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference

Xu, M.; Koeltzow, T.E.; Cooper, D.C.; Tonegawa, S.; White, F.J., 1999:
Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists

Kahsar Miller, M.; Boots, L.R.; Azziz, R., 1999:
Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome

Rietschel, M.; Krauss, H.; Mueller, D.J.; Schulze, T.G.; Knapp, M.; Marwinski, K.; Maroldt, A.O.to; Paus, S.; Gruenhage, F.; Propping, P.; Maier, W.; Held, T.; Noethen, M.M., 2000:
Dopamine D3 receptor variant and tardive dyskinesia

Luippold, G.; Zimmermann, C.; Mai, M.; Kloor, D.; Starck, D.; Gross, G.; Mühlbauer, B., 2001:
Dopamine D(3) receptors and salt-dependent hypertension

Robinet, P.M.; Bardo, M.T., 2001:
Dopamine D3 receptors are involved in amphetamine-induced contralateral rotation in 6-OHDA lesioned rats

Diaz, J.; Pilon, C.; Le Foll, B.; Gros, C.; Triller, A.; Schwartz, J.C.; Sokoloff, P., 2000:
Dopamine D3 receptors expressed by all mesencephalic dopamine neurons

Mühlbauer, B.; Küster, E.; Luippold, G., 2000:
Dopamine D(3) receptors in the rat kidney: role in physiology and pathophysiology

Yamada, S.; Harano, M.; Annoh, N.; Tanaka, M., 1999:
Dopamine D(3) receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum

Oak, J.N.; Lavine, N.; Van Tol, H.H., 2001:
Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor

Faraone, S.V.; Biederman, J.; Weiffenbach, B.; Keith, T.; Chu, M.P.; Weaver, A.; Spencer, T.J.; Wilens, T.E.; Frazier, J.; Cleves, M.; Sakai, J., 1999:
Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder

Price, C.J.; Pittman, Q.J., 2001:
Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus

Jentsch, J.D.vid; Taylor, J.R.; Redmond, D.E.gene, J.; Elsworth, J.D.; Youngren, K.D.; Roth, R.H., 1999:
Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys

Ricci, A.; Marchal-Victorion, S.; Bronzetti, E.; Parini, A.; Amenta, F.; Tayebati, S.K., 2002:
Dopamine D4 receptor expression in rat kidney: evidence for pre- and postjunctional localization

Bau, C.H.; Roman, T.; Almeida, S.; Hutz, M.H., 1999:
Dopamine D4 receptor gene and personality dimensions in Brazilian male alcoholics

Persson, M.L.; Wasserman, D.; Geijer, T.; Frisch, A.; Rockah, R.; Michaelovsky, E.; Apter, A.; Weizman, A.; Jonsson, E.G.; Bergman, H., 2000:
Dopamine D4 receptor gene polymorphism and personality traits in healthy volunteers

Paterson, A.D.; Sunohara, G.A.; Kennedy, J.L., 1999:
Dopamine D4 receptor gene: novelty or nonsense?

Rubinstein, M.; Cepeda, C.; Hurst, R.S.; Flores-Hernandez, J.; Ariano, M.A.; Falzone, T.L.; Kozell, L.B.; Meshul, C.K.; Bunzow, J.R.; Low, M.J.; Levine, M.S.; Grandy, D.K., 2001:
Dopamine D4 receptor-deficient mice display cortical hyperexcitability

Dulawa, S.C.; Grandy, D.K.; Low, M.J.; Paulus, M.P.; Geyer, M.A., 1999:
Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli

Alfinito, P.D.; Townes Anderson, E., 2001:
Dopamine D4 receptor-mediated regulation of rod opsin mRNA expression in tiger salamander

Helmeste, D.M.; Tang, S.W., 2000:
Dopamine D4 receptors

Kulkarni, S.K.; Ninan, I., 2000:
Dopamine D4 receptors and development of newer antipsychotic drugs

Rivera, A.; Ceullar, B.; Giron, F.J.; Grandy, D.K.; D.L.C.lle, A.; Moratalla, R., 2002:
Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum

Zhang, K.; Tarazi, F.I.; Baldessarini, R.J., 2000:
Dopamine D4 receptors in rat forebrain: Unchanged with amphetamine-induced behavioral sensitization

Wang, X.; Zhong, P.; Yan, Z., 2002:
Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex

Simpson, M.M.; Ballesteros, J.A.; Chiappa, V.; Chen, J.; Suehiro, M.; Hartman, D.S.; Godel, T.; Snyder, L.A.; Sakmar, T.P.; Javitch, J.A., 1999:
Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments

Demchyshyn, L.L.; McConkey, F.; Niznik, H.B., 2000:
Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence

Wang, J.; Liu, Z.L.n; Chen, B., 2001:
Dopamine D5 receptor gene polymorphism and the risk of levodopa-induced motor fluctuations in patients with Parkinson's disease

Ciliax, B.J.; Nash, N.; Heilman, C.; Sunahara, R.; Hartney, A.; Tiberi, M.; Rye, D.B.; Caron, M.G.; Niznik, H.B.; Levey, A.I., 2000:
Dopamine D(5) receptor immunolocalization in rat and monkey brain

Khan, Z.U.; Gutierrez, A.; Martin, R.; Penafiel, A.; Rivera, A.; D.L.C.lle, A., 2000:
Dopamine D5 receptors of rat and human brain

Bartrés-Faz, D.; Junqué, C.; Serra-Grabulosa, J.M.; López-Alomar, A.; Moya, A.; Bargalló, Núria.; Mercader, J.M.; Moral, P.; Clemente, I.C., 2002:
Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects

Ray, M.R.; Lakshmi, C.; Deb, C.; Pal, B., 2000:
Dopamine accelerates recovery from cyclophosphamide-induced leukopenia

Scheller, C.; Sopper, S.; Jassoy, C.; Ter Meulen, V.; Riederer, P.; Koutsilieri, E., 2000:
Dopamine activates HIV in chronically infected T lymphoblasts: Rapid communication

Uchida, S.; Akaike, N.; Nabekura, J., 2000:
Dopamine activates inward rectifier K+ channel in acutely dissociated rat substantia nigra neurones

Wersinger, S.R.; Rissman, E.F., 2000:
Dopamine activates masculine sexual behavior independent of the estrogen receptor alpha

Cornil, C.A.; Balthazart, J.; Motte, P.; Massotte, L.; Seutin, V., 2002:
Dopamine activates noradrenergic receptors in the preoptic area

Magoski, N.S.; Bulloch, A.G., 1999:
Dopamine activates two different receptors to produce variability in sign at an identified synapse

Piomelli, D.; Giuffrida, A.; Parsons, L.H.; Rodriguez, D.F.nseca, F.; Navarro, M., 1999:
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

Hu, M.C.; Fan, L.; Crowder, L.A.; Karim-Jimenez, Z.; Murer, H.; Moe, O.W., 2001:
Dopamine acutely stimulates Na+/H+ exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation

Porter, L.L.; Rizzo, E.; Hornung, J.P., 1999:
Dopamine affects parvalbumin expression during cortical development in vitro

Reuter, M.; Netter, P.; Toll, C.; Hennig, J., 2002:
Dopamine agonist and antagonist responders as related to types of nicotine craving and facets of extraversion

Swerdlow, N.R.; Eastvold, A.; Karban, B.; Ploum, Y.; Stephany, N.; Geyer, M.A.; Cadenhead, K.; Auerbach, P.P., 2002:
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies

Boraud, T.; Bezard, E.; Bioulac, B.; Gross, C.E., 2001:
Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey

Ruskin, D.N.; Bergstrom, D.A.; Mastropietro, C.W.; Twery, M.J.; Walters, J.R., 1999:
Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei

Schapira, A.H.V., 2002:
Dopamine agonists and neuroprotection in Parkinson's disease

Cantor, C.R.; Stern, M.B., 2002:
Dopamine agonists and sleep in Parkinson's disease

Chang, A.; Shin, S.H., 1999:
Dopamine agonists both stimulate and inhibit prolactin release in GH4ZR7 cells

Grujic, Z.; Mapstone, M.; Gitelman, D.R.; Johnson, N.; Weintraub, S.; Hays, A.; Kwasnica, C.; Harvey, R.; Mesulam, M.M., 1998:
Dopamine agonists reorient visual exploration away from the neglected hemispace

Brooks, D.J., 2000:
Dopamine agonists: their role in the treatment of Parkinson's disease

Rascol, O., 1999:
Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?

Cartmell, J.; Salhoff, C.R.; Perry, K.W.; Monn, J.A.; Schoepp, D.D., 2000:
Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum

Lin, J.Y.ng; Yen, S.H.i; Shieh, K.R.ey; Liang, S.L.ng; Pan, J.T.er, 2000:
Dopamine and 7-OH-DPAT may act on D3 receptors to inhibit tuberoinfundibular dopaminergic neurons

Tanaka, M.; Yoshida, T.; Okamoto, K.; Hirai, S., 1999:
Dopamine and DOPA cause release of iron from ferritin and lipid peroxidation of liposomes

Izaki, Y.; Hori, K.; Nomura, M., 1998:
Dopamine and acetylcholine elevation on lever-press acquisition in rat prefrontal cortex

Kombian, S.B.; Ananthalakshmi, K.V.V.; Parvathy, S.S.; Matowe, W.C., 2003:
Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro

Walter, H.; Ramskogler, K.; Semler, B.; Lesch, O.M.chael; Platz, W., 2001:
Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials

Sopchak, D.; Miller, B.; Kalish, R.; Avyigal, Y.; Shi, X., 2002:
Dopamine and ascorbate analysis at hydrodynamic electrodes of boron doped diamond and nitrogen incorporated tetrahedral amorphous carbon

Calabresi, P.; Gubellini, P.; Centonze, D.; Picconi, B.; Bernardi, G.; Chergui, K.; Svenningsson, P.; Fienberg, A.A.; Greengard, P., 2000:
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity

Kozicz, Tamas, 2003:
Dopamine and cyclic AMP-regulated phosphoprotein immunoreactive neurons are innervated by axon terminals immunopositive for vasoactive intestinal polypeptide in the bed nuclei of the stria terminalis and central nucleus of the amygdala

Berke, J.D.; Sgambato, V.; Zhu, P.P.ng; Lavoie, B.; Vincent, M.; Krause, M.; Hyman, S.E., 2001:
Dopamine and glutamate induce distinct striatal splice forms of ania-6, an RNA polymerase II-associated cyclin

Jacobsson, S.O.P.; Fowler, C.J., 1999:
Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: Effects of NMDA antagonists, antioxidants and MAO inhibitors

You, Z.B.; Chen, Y.Q.; Wise, R.A., 2001:
Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation

Floresco, S.B.; Phillips, A.G., 1999:
Dopamine and hippocampal input to the nucleus accumbens play an essential role in the search for food in an unpredictable environment

Pulver, S.R.; Thirumalai, V.; Richards, K.S.; Marder, E., 2003:
Dopamine and histamine in the developing stomatogastric system of the lobster Homarus americanus

Rihet, P.; Possamaï, C-Aimé.; Micallef-Roll, Jëlle.; Blin, O.; Hasbroucq, T., 2002:
Dopamine and human information processing: a reaction-time analysis of the effect of levodopa in healthy subjects

Giuliano, F.; Allard, J., 2002:
Dopamine and male sexual function

Sita, L.V.; Elias, C.F.; Bittencourt, J.C., 2003:
Dopamine and melanin-concentrating hormone neurons are distinct populations in the rat rostromedial zona incerta

Barbanti, P.; Fabbrini, G.; Vanacore, N.; Rum, A.; Lenzi, G.L.; Meco, G.; Cerbo, R., 2000:
Dopamine and migraine: Does Parkinson's disease modify migraine course?

Haamedi, S.N.; Djamgoz, M.B.A., 2002:
Dopamine and nitric oxide control both flickering and steady-light-induced cone contraction and horizontal cell spinule formation in the teleost (carp) retina: serial interaction of dopamine and nitric oxide

Feenstra, M.G.P.; Botterblom, M.H.A.; Mastenbroek, S., 2000:
Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: Effects of novelty and handling and comparison to the nucleus accumbens

Feenstra, M.G.P.; Vogel, M.; Botterblom, M.H.A.; Joosten, R.N.J.M.A.; D.B.uin, J.P.C., 2001:
Dopamine and noradrenaline efflux in the rat prefrontal cortex after classical aversive conditioning to an auditory cue

Feenstra, M.G.P.; Teske, G.; Botterblom, M.H.A.; D.B.uin, J.P.C., 1999:
Dopamine and noradrenaline release in the prefrontal cortex of rats during classical aversive and appetitive conditioning to a contextual stimulus: Interference by novelty effects

Neckameyer, W.S.; Woodrome, S.; Holt, B.; Mayer, A., 2000:
Dopamine and senescence in Drosophila melanogaster

Neckameyer, W.; O'donnell, J.; Huang, Z.; Stark, W., 2001:
Dopamine and sensory tissue development in Drosophila melanogaster

Duval, F.; Mokrani, M.C.aude; Monreal, J.; Bailey, P.; Valdebenito, M.; Crocq, M.A.toine; Macher, J.P.ul, 2003:
Dopamine and serotonin function in untreated schizophrenia: Clinical correlates of the apomorphine and d-fenfluramine tests

Heidbreder, C.A.; Oertle, T.; Feldon, J., 1999:
Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine

Gervais, J.; Soghomonian, J.J.; Richard, D.; Rouillard, C., 1999:
Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum

Kiss, T.; Hiripi, L.; Papp, N.; Elekes, K., 2003:
Dopamine and serotonin receptors mediating contractions of the snail, Helix Pomatia, salivary duct

Yoshimoto, K.; Kato, B.; Ueda, S.; Noritake, K.; Sakai, K.; Shibata, M.; Hori, M.; Kawano, H.; Takeuchi, Y.; Wakabayashi, Y.; Yasuhara, M., 2001:
Dopamine and serotonin uptake inhibitors on the release of dopamine and serotonin in the nucleus accumbens of young and aged rats

Arbuthnott, G.W.; Ingham, C.A.; Wickens, J.R., 2000:
Dopamine and synaptic plasticity in the neostriatum

Lee, A.C.; Harris, J.P.; Atkinson, E.A.; Nithi, K.; Fowler, M.S., 2002:
Dopamine and the representation of the upper visual field: Evidence from vertical bisection errors in unilateral Parkinson's disease

Lopez, H.H.; Ettenberg, A., 2001:
Dopamine antagonism attenuates the unconditioned incentive value of estrous female cues

Besheer, J.; Jensen, H.C.; Bevins, R.A., 1999:
Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats

Salamone, J.D.; Arizzi, M.N.; Sandoval, M.D.; Cervone, K.M.; Aberman, J.E., 2002:
Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task

Wang, P.S.; Walker, A.M.; Tsuang, M.T.; Orav, E.John.; Glynn, R.J.; Levin, R.; Avorn, J., 2002:
Dopamine antagonists and the development of breast cancer

Byrnes, E.M.; Rigero, B.A.; Bridges, R.S., 2002 :
Dopamine antagonists during parturition disrupt maternal care and the retention of maternal behavior in rats

Zavitsanou, K.; Cranney, J.; Richardson, R., 1999:
Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat

Yasunari, K.; Maeda, K.; Nakamura, M.; Yoshikawa, J., 2003:
Dopamine as a novel anti-migration factor of vascular smooth muscle cells through D1A and D1B receptors

Yasunari, K.; Kohno, M.; Kano, H.; Minami, M.; Yoshikawa, J., 2000:
Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors

Rosenkranz, J.A.; Grace, A.A., 2001:
Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats

Ekesbo, A.; Rydin, E.; Torstenson, R.; Sydow, O.; Låengström, B.; Tedroff, J., 1999:
Dopamine autoreceptor function is lost in advanced Parkinson's disease

Joseph, J.D.; Wang, Y.M.; Miles, P.R.; Budygin, E.A.; Picetti, R.; Gainetdinov, R.R.; Caron, M.G.; Wightman, R.M., 2002:
Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D3 receptors

Alaniz, R.C.; Thomas, S.A.; Perez-Melgosa, M.; Mueller, K.; Farr, A.G.; Palmiter, R.D.; Wilson, C.B., 1999:
Dopamine beta-hydroxylase deficiency impairs cellular immunity

Slama, P.; Jabre, F.; Tron, T.; Réglier, M., 2001:
Dopamine beta-hydroxylase inactivation generates a protein-bound quinone derivative

Oyarce, A.M.; Steveson, T.C.; Jin, L.; Eipper, B.A., 2001:
Dopamine beta-monooxygenase signal/anchor sequence alters trafficking of peptidylglycine alpha-hydroxylating monooxygenase

Rodríguez, M.; Barroso-Chinea, P.; Abdala, P.; Obeso, J.; González-Hernández, T., 2001:
Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease

Sinclair, S.R.; Fawcett, J.W.; Dunnett, S.B., 1999:
Dopamine cells in nigral grafts differentiate prior to implantation

D.B.uin, N.M.W.J.; Van Luijtelaar, E.L.J.M.; Jansen, S.J.; Cools, A.R.; Ellenbroek, B.A., 2000:
Dopamine characteristics in different rat genotypes: The relation to absence epilepsy

de Bruin, N.M.; van Luijtelaar, E.L.; Cools, A.R.; Ellenbroek, B.A., 2001:
Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation

Fauchey, V.; Jaber, M.; Bloch, B.; L.M.ine, C., 2000:
Dopamine control of striatal gene expression during development: Relevance to knockout mice for the dopamine transporter

Tanaka, Shoji, 2002:
Dopamine controls fundamental cognitive operations of multi-target spatial working memory

Jaliffa, C.O.; Lacoste, F.F.; Llomovatte, D.W.; Sarmiento, M.I.; Rosenstein, R.E., 2000:
Dopamine decreases melatonin content in golden hamster retina

Gulledge, A.T.; Jaffe, D.B., 1998:
Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex

Kobayashi, K.; Sano, H., 2000:
Dopamine deficiency in mice

Levein, N.G.; Thorn, S.E.; Wattwil, M., 1999:
Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers

Florio, T.; Capozzo, A.; Nisini, A.; Lupi, A.; Scarnati, E., 1999:
Dopamine denervation of specific striatal subregions differentially affects preparation and execution of a delayed response task in the rat

Brown, P.; Oliviero, A.; Mazzone, P.; Insola, A.; Tonali, P.; Di Lazzaro, V., 2001:
Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease

Balcioglu, A.; Zhang, K.; Tarazi, F.I., 2003:
Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: A microdialysis study

Cho, J.; Duke, D.; Manzino, L.; Sonsalla, P.K.; West, M.O., 2002:
Dopamine depletion causes fragmented clustering of neurons in the sensorimotor striatum: evidence of lasting reorganization of corticostriatal input

Beyer, C.E.; Steketee, J.D., 1999:
Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine

Powell, S.B.; Geyer, M.A.; Preece, M.A.; Pitcher, L.K.; Reynolds, G.P.; Swerdlow, N.R., 2003:
Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats

Fan, S.F.; Yazulla, S., 2001:
Dopamine depletion with 6-OHDA enhances dopamine D1-receptor modulation of potassium currents in retinal bipolar cells

Bek, M.; Fischer, K.G.; Greiber, S.; Hupfer, C.; Mundel, P.; Pavenstädt, H., 1999:
Dopamine depolarizes podocytes via a D1-like receptor

Behr, J.; Gloveli, T.; Schmitz, D.; Heinemann, U., 2000:
Dopamine depresses excitatory synaptic transmission onto rat subicular neurons via presynaptic D1-like dopamine receptors

Chen, X.; Kombian, S.B.; Zidichouski, J.A.; Pittman, Q.J., 1999:
Dopamine depresses glutamatergic synaptic transmission in the rat parabrachial nucleus in vitro

Behr, J.; Gloveli, T.; Schmitz, D.; Heinemann, U., 2000:
Dopamine depresses polysynaptic inhibition in rat subicular neurons

Hsia, A.Y.; Vincent, J.D.; Lledo, P.M., 1999:
Dopamine depresses synaptic inputs into the olfactory bulb

Seeman, P.; Tallerico, T.; Ko, F., 2003:
Dopamine displaces (3H)domperidone from high-affinity sites of the dopamine D2 receptor, but not (3H)raclopride or (3H)spiperone in isotonic medium: Implications for human positron emission tomography

Solanto, Mary, V., 2002:
Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research

Elkashef, A.M.; A.B.razi, H.; Venable, D.; Baker, I.; Hill, J.; Apud, J.; Wyatt, R.J.d, 2002:
Dopamine effect on the mitochondria potential in B lymphocytes of schizophrenic patients and normal controls

Liu, Yu; Luo, F.J.n; Liang, Pei Ji, 2003:
Dopamine effect on the stimulus pattern related changes in response characteristics of R/G horizontal cells in carp retina

Obata, T., 2002:
Dopamine efflux by MPTP and hydroxyl radical generation

Itokawa, M.; Lin, Z.; Uhl, G.R., 2002:
Dopamine efflux via wild-type and mutant dopamine transporters: Alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations

Flores-Hernández, J.; Cepeda, C.; Hernández-Echeagaray, E.; Calvert, C.R.; Jokel, E.S.; Fienberg, A.A.; Greengard, P.; Levine, M.S., 2002:
Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32

Gonzalez-Islas, C.; Hablitz, J.J., 2003:
Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex

Berndt, T.J.; Tucker, R.R.; Kent, P.D.; Streiff, P.C.; Tyce, G.M.; Knox, F.G., 1999:
Dopamine enhances the phosphaturic effect of PTH during acute respiratory alkalosis

Bracci, E.; Centonze, D.; Bernardi, G.; Calabresi, P., 2002:
Dopamine excites fast-spiking interneurons in the striatum

Hussain, T.; Becker, M.; Beheray, S.; Lokhandwala, M.F., 2001:
Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats

Ranaldi, R.; Pocock, D.; Zereik, R.; Wise, R.A., 1999:
Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration

Maleck, W.H.; Piper, S.N.; Koetter, K.P., 2003:
Dopamine for renal protection

Nyhan, W.L., 2000:
Dopamine function in Lesch-Nyhan disease

Brambilla, F.; Perna, G.; Bussi, R.; Bellodi, L., 2000:
Dopamine function in obsessive compulsive disorder: Cortisol response to acute apomorphine stimulation

O'donnell, Patricio, 2003:
Dopamine gating of forebrain neural ensembles

Horvitz, Jon, C., 2002:
Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum

DiMaio, S.; Grizenko, N.; Joober, R., 2003:
Dopamine genes and attention-deficit hyperactivity disorder: a review

Ogilvie, J.M.singer; Speck, J.D., 2002:
Dopamine has a critical role in photoreceptor degeneration in the rd mouse

Heinz, A., 2000:
Dopamine hypothesis of schizophrenia. New findings support a traditional theory

Brownell, A.L.; Jenkins, B.G.; Isacson, O., 1999:
Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease

Marai, I.; Levi, Y., 2001:
Dopamine in acute renal failure

Smit, A.J., 2000:
Dopamine in heart failure and critical care

Svennilson, J.; Aperia, A., 1999:
Dopamine in the developing kidney

Kiyatkin, Eugene, A., 2002:
Dopamine in the nucleus accumbens: Cellular actions, drug- and behavior-associated fluctuations, and a possible role in an organism's adaptive activity

Deransart, C.; Riban, V.; Le, B.T.; Marescaux, C.; Depaulis, A., 2000:
Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat

Henze, D.A.; González-Burgos, G.R.; Urban, N.N.; Lewis, D.A.; Barrionuevo, G., 2000:
Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex

Khan, F.H.ssain; Saha, M.; Chakrabarti, S., 2001:
Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain

Vindis, C.; Séguélas, M.H.; Lanier, S.; Parini, A.; Cambon, C., 2001:
Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase

Brami-Cherrier, K.; Valjent, E.; Garcia, M.; Pagès, C.; Hipskind, R.A.; Caboche, J., 2002:
Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation

Ray, M.-Ranjan; Lahiri, T., 2000:
Dopamine induces apoptosis in murine tumor cells in vivo

Gómez-Santos, C.; Ferrer, I.; Santidrián, A.F.; Barrachina, M.; Gil, J.; Ambrosio, S., 2003:
Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells

Rey, E.; Hernández-Díaz, F.J.; Abreu, P.; Alonso, R.; Tabares, L., 2001:
Dopamine induces intracellular Ca2+ signals mediated by alpha1B-adrenoceptors in rat pineal cells

Sookhai, S.; Wang, J.H.; Mccourt, M.; O'connell, D.; Redmond, H.P., 1999:
Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor-independent mechanism

Keller, J.N.; Huang, F.F.; Dimayuga, E.R.; Maragos, W.F., 2000:
Dopamine induces proteasome inhibition in neural PC12 cell line

Berger, S.P.; Hünger, M.; Yard, B.A.; Schnuelle, P.; Van Der Woude, F.J., 2000:
Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro

Ruel, J.; Nouvian, R.; Gervais D'aldin, C.; Pujol, R.; Eybalin, M.; Puel, J.L.c, 2001:
Dopamine inhibition of auditory nerve activity in the adult mammalian cochlea

Gonzalez-Islas, C.; Hablitz, J.J., 2001:
Dopamine inhibition of evoked IPSCs in rat prefrontal cortex

Nakashima, A.; Mori, K.; Suzuki, T.; Kurita, H.; Otani, M.; Nagatsu, T.; Ota, A., 1999:
Dopamine inhibition of human tyrosine hydroxylase type 1 is controlled by the specific portion in the N-terminus of the enzyme

Alcayaga, J.; Retamal, M.; Cerpa, V.; Arroyo, J.; Zapata, P., 2003:
Dopamine inhibits ATP-induced responses in the cat petrosal ganglion in vitro

Beheray, S.A.; Hussain, T.; Lokhandwala, M.F., 2000:
Dopamine inhibits na,h-exchanger via D1-like receptor-mediated stimulation of protein kinase a in renal proximal tubules

Ghosh, M.Chandra.; Mondal, A.Chandra.; Basu, S.; Banerjee, S.; Majumder, J.; Bhattacharya, D.; Dasgupta, P.Sarathi., 2003:
Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells

Tosini, G.; Dirden, J.C., 2000:
Dopamine inhibits melatonin release in the mammalian retina: In vitro evidence

Kunimi, M.; Seki, G.; Hara, C.; Taniguchi, S.; Uwatoko, S.; Goto, A.; Kimura, S.; Fujita, T., 2000:
Dopamine inhibits renal Na+:HCO3- cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats

Edwards, R.M.; Brooks, D.P., 2001:
Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors

Sesack, S.R.; Hawrylak, V.A.; Melchitzky, D.S.; Lewis, D.A., 1998:
Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures

Erickson, S.L.; Sesack, S.R.; Lewis, D.A., 2000:
Dopamine innervation of monkey entorhinal cortex: postsynaptic targets of tyrosine hydroxylase-immunoreactive terminals

Levite, M.; Chowers, Y.; Ganor, Y.; Besser, M.; Hershkovits, R.; Cahalon, L., 2001:
Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function

Furutama, K.; Sakuma, Y.; Kato, Y.; Tamura, M.; Mori, N.; Oka, M.; Yoshikawa, H.; Ueda, Y., 1999:
Dopamine matabolism during orofacial pain in the rat prefrontal cortex

Oades, Robert, D., 2002:
Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder

Takamatsu, I.; Karasawa, F.; Okuda, T., 2002:
Dopamine may preserve the myocardial oxygen balance better than dobutamine when administered with milrinone

Ribelayga, C.; Wang, Y.; Mangel, S.C., 2002:
Dopamine mediates circadian clock regulation of rod and cone input to fish retinal horizontal cells

Manglapus, M.K.; Iuvone, P.M.; Underwood, H.; Pierce, M.E.; Barlow, R.B., 1999:
Dopamine mediates circadian rhythms of rod-cone dominance in the Japanese quail retina

Xia, X.G.ng; Schmidt, N.; Teismann, P.; Ferger, B.; Schulz, J.B., 2001:
Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation

Roitman, M.F.; Van Dijk, G.; Thiele, T.E.; Bernstein, I.L., 2001:
Dopamine mediation of the feeding response to violations of spatial and temporal expectancies

Okada, Yukio; Miyamoto, Takenori; Toda, Kazuo, 2003:
Dopamine modulates a voltage-gated calcium channel in rat olfactory receptor neurons

Bainton, R.J.; Tsai, L.T.Y.; Singh, C.M.; Moore, M.S.; Neckameyer, W.S.; Heberlein, U., 2000:
Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila

Alcayaga, J.; Varas, R.; Arroyo, J.; Iturriaga, R.; Zapata, P., 1999:
Dopamine modulates carotid nerve responses induced by acetylcholine on the cat petrosal ganglion in vitro

Ohtani, N.; Goto, T.; Waeber, C.; Bhide, P.G., 2003:
Dopamine modulates cell cycle in the lateral ganglionic eminence

Ding, L.; Perkel, D.J., 2002:
Dopamine modulates excitability of spiny neurons in the avian basal ganglia

Mansvelder, H.D.; Lodder, J.C.; Sons, Mèle.S.; Kits, K.S., 2002:
Dopamine modulates exocytosis independent of Ca(2+) entry in melanotropic cells

Kahkonen, S.; Ahveninen, J.; Pekkonen, E.; Kaakkola, S.; Huttunen, J.; Ilmoniemi, R.J.; Jaaskelainen, IIro, P., 2002:
Dopamine modulates involuntary attention shifting and reorienting: An electromagnetic study

Vargas, G.; Lucero, M.T., 1999:
Dopamine modulates inwardly rectifying hyperpolarization-activated current (Ih) in cultured rat olfactory receptor neurons

El-Mas, M.M.; Elmallah, A.I.; Omar, A.G.; Sharabi, F., 1999:
Dopamine modulates peripheral purinergic neurotransmission through multiple presynaptic receptors: tissue-dependent effects

Sun, W.; Salvi, R.J., 2001:
Dopamine modulates sodium currents in cochlear spiral ganglion neurons

Davila, N.G.; Blakemore, L.J.; Trombley, P.Q., 2003:
Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture

Kline, D.D.; Takacs, K.N.; Ficker, E.; Kunze, D.L., 2002:
Dopamine modulates synaptic transmission in the nucleus of the solitary tract

Wittmann, M.; Marino, M.J.; Conn, P.Jeffrey., 2002:
Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata

Tessitore, A.; Hariri, A.R.; Fera, F.; Smith, W.G.; Chase, T.N.; Hyde, T.M.; Weinberger, D.R.; Mattay, V.S., 2002:
Dopamine modulates the response of the human amygdala: a study in Parkinson's disease

Lavin, A.; Grace, A.A., 1998:
Dopamine modulates the responsivity of mediordorsal thalamic cells recorded in vitro

Reynolds, D.S.; Carter, R.J.; Morton, A.J., 1998:
Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease

Kloppenburg, P.; Levini, R.M.; Harris-Warrick, R.M., 1999:
Dopamine modulates two potassium currents and inhibits the intrinsic firing properties of an identified motor neuron in a central pattern generator network

Storozhuk, V.M.; Khorevin, V.I.; Rozumna, N.M.; Villa, A.E.P.; Tetko, I.V., 2002:
Dopamine modulation of activity of cat sensorimotor cortex neurons during conditioned reflexes

Zhou, F.M.; Hablitz, J.J., 1999:
Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex

Onn, S-Pii.; Fienberg, A.A.; Grace, A.A., 2003:
Dopamine modulation of membrane excitability in striatal spiny neurons is altered in DARPP-32 knockout mice

Gonzalez Burgos, G.; Kroner, S.; Krimer, L.S.; Seamans, J.K.; Urban, N.N.; Henze, D.A.; Lewis, D.A.; Barrionuevo, G., 2002:
Dopamine modulation of neuronal function in the monkey prefrontal cortex

Gao, W-Jun.; Wang, Y.; Goldman-Rakic, P.S., 2003:
Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex

Jones, S.R.; Joseph, J.D.; Barak, L.S.; Caron, M.G.; Wightman, R.M.rk, 1999:
Dopamine neuronal transport kinetics and effects of amphetamine

Eells, J.B.; Yeung, S.K.; Nikodem, V.M., 2002:
Dopamine neurons heterozygous for the Nurr1-null allele have reduced survival in vitro

Schatz, D.S.; Kaufmann, W.A.; Saria, A.; Humpel, C., 1999:
Dopamine neurons in a simple GDNF-treated meso-striatal organotypic co-culture model

Hollerman, J.R.; Schultz, W., 1998:
Dopamine neurons report an error in the temporal prediction of reward during learning

Cantuti Castelvetri, I.; Shukitt Hale, B.; Joseph, J.A., 2003:
Dopamine neurotoxicity: Age-dependent behavioral and histological effects

Masi, F.; Scheggi, S.; Mangiavacchi, S.; Tolu, P.; Tagliamonte, A.; D.M.ntis, M.G.aziella; Gambarana, C., 2001:
Dopamine output in the nucleus accumbens shell is related to the acquisition and the retention of a motivated appetitive behavior in rats

Berman, S.B.; Hastings, T.G., 1999:
Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease

Khan, F.Hossain.; Sen, T.; Chakrabarti, S., 2003:
Dopamine oxidation products inhibit Na+, K+-ATPase activity in crude synaptosomal-mitochondrial fraction from rat brain

Orsini, C.; Koob, G.F.; Pulvirenti, L., 2001:
Dopamine partial agonist reverses amphetamine withdrawal in rats

Miyaguchi, H.; Kato, I.; Sano, T.; Sobajima, H.; Fujimoto, S.; Togari, H., 1999:
Dopamine penetrates to the central nervous system in developing rats

Ray, M.-Ranjan; Lakshmi, C.; Pal, B., 2000:
Dopamine pretreatment in mice diminishes the hematotoxic effects of cyclophosphamide

Park, S.; Geddes, T.J.; Javitch, J.A.; Kuhn, D.M., 2003:
Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage?

Szczypka, M., S.; Kwok, K.; Brot, M., D.; Marck, B., T.; Matsumoto, A., M.; Donahue, B., A.; Palmiter, R., D., 2001:
Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice

Feron, F.; Vincent, A.; Mackay Sim, A., 1999:
Dopamine promotes differentiation of olfactory neuron in vitro

Loupe, P.S.; Bredemeier, J.D.; Schroeder, S.R.; Tessel, R.E., 2002:
Dopamine re-uptake inhibitor GBR-12909 induction of aberrant behaviors in animal models of dopamine dysfunction

Serretti, A.; Macciardi, F.; Smeraldi, E., 1998:
Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia

Benedetti, F.; Serretti, A.; Colombo, C.; Lilli, R.; Lorenzi, C.; Smeraldi, E., 2003:
Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression

Serretti, A.; Lilli, R.; Lorenzi, C.; Franchini, L.; Di Bella, D.; Catalano, M.; Smeraldi, E., 1999:
Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders

Pastor, P.; Munoz, E.; Obach, V.; Marti, M.J.se; Blesa, R.; Oliva, R.; Tolosa, E., 1999:
Dopamine receptor D2 intronic polymorphism in patients with Parkinson's disease

Serretti, A.; Lilli, R.; Di Bella, D.; Bertelli, S.; Nobile, M.; Novelli, E.; Catalano, M.; Smeraldi, E., 1999:
Dopamine receptor D4 gene is not associated with major psychoses

Serretti, A.; Benedetti, F.; Colombo, C.; Lilli, R.; Lorenzi, C.; Smeraldi, E., 1999:
Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation

Armentero, M.T.erese; Fancellu, R.; Nappi, G.; Blandini, F., 2002:
Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat

Dwyer, D., S.; Liu, Y.; Bradley, R., J., 1999:
Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells

Bast, T.; Pezze, M.A.; Feldon, J., 2002:
Dopamine receptor blockade in the rat medial prefrontal cortex reduces spontaneous and amphetamine-induced activity and does not affect prepulse inhibition

Coronas, V.; Krantic, S.; Jourdan, F.; Moyse, E., 1999:
Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: A combined pharmacological-radioautographic approach

Mckenna, F.; Mclaughlin, P.J.; Lewis, B.J.; Sibbring, G.C.; Cummerson, J.A.; Bowen Jones, D.; Moots, R.J., 2002:
Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: A flow cytometric study

Wong, A.H.ng Choy; Knapp, M.G.L.; Van Tol, H.H.M., 2000:
Dopamine receptor gene transfer into rat striatum using a recombinant adenoviral vector: Rotational behaviour

Shepherd, A.G.aeme; Lea, R.A.; Hutchins, C.; Jordan, K.L.; Brimage, P.J.; Griffiths, L.R., 2002:
Dopamine receptor genes and migraine with and without aura: An association study

Miller, W.B.; Pasta, D.J.; MacMurray, J.; Chiu, C.; Wu, H.; Comings, D.E., 1999:
Dopamine receptor genes are associated with age at first sexual intercourse

Tsai, S.J.n; Hong, C.J.e, 2003:
Dopamine receptor hetero-oligomerization: A hypothesis for behavioral sensitization to psychostimulants

Mignini, F.; Bronzetti, E.; Felici, L.; Ricci, A.; Sabbatini, M.; Tayebati, S.K.; Amenta, F., 2000:
Dopamine receptor immunohistochemistry in the rat choroid plexus

Nguyen-Legros, J.; Versaux-Botteri, C.; Vernier, P., 1999:
Dopamine receptor localization in the mammalian retina

Zarrindast, M-Reza.; Dinkoub, Z.; Homayoun, H.; Bakhtiarian, A.; Khavandgar, S., 2002:
Dopamine receptor mechanism(s) and morphine tolerance in mice

Markianos, M.; Moussas, G.; Lykouras, L.; Hatzimanolis, J., 2000:
Dopamine receptor responsivity in alcoholic patients before and after detoxification

Markianos, M.; Hatzimanolis, J.; Lykouras, L., 1999:
Dopamine receptor responsivity in schizophrenic patients before and after switch from haloperidol to risperidone

Lykouras, L.; Markianos, M.; Hatzimanolis, J.; Oulis, P., 2001:
Dopamine receptor responsivity in schizophrenic patients in a drug-free state and after treatment with olanzapine

Ninan, I.; Kulkarni, S.K., 1998:
Dopamine receptor sensitive effect of dizocilpine on feeding behaviour

Chandhoke, V.; Southall, M.; Holt, R.; Flinn, J.M., 2001:
Dopamine receptor subtype density as a function of age in Aplysia californica

Brünig, I.; Sommer, M.; Hatt, H.; Bormann, J., 1999:
Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors

Bergson, C.; Levenson, R.; Goldman-Rakic, P.S.; Lidow, M.S., 2003:
Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling

Otani, S.; Auclair, N.; Desce, J.M.; Roisin, M.P.; Crépel, F., 1999:
Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases

Kram, M.L.; Kramer, G.L.; Ronan, P.J.; Steciuk, M.; Petty, F., 2002:
Dopamine receptors and learned helplessness in the rat: An autoradiographic study

Sealfon, S.C., 2000:
Dopamine receptors and locomotor responses: molecular aspects

Tupala, E.; Hall, H.; Mantere, T.; Rasanen, P.; Sarkioja, T.; Tiihonen, J., 2003:
Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography

Ricci, A.; Bronzetti, E.; Mannino, F.; Mignini, F.; Morosetti, C.; Tayebati, S.K.; Amenta, F., 2001:
Dopamine receptors in human platelets

Kestler, L.P.; Walker, E.; Vega, E.M., 2001:
Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings

Hemsley, K.M.; Farrall, E.J.; Crocker, A.D., 2002:
Dopamine receptors in the subthalamic nucleus are involved in the regulation of muscle tone in the rat

Sealfon, S.C.; Olanow, C.W.rren, 2000:
Dopamine receptors: from structure to behavior

Levein, N.G.; Thorn, S.E.; Lindberg, G.; Wattwil, M., 1999:
Dopamine reduces gastric tone in a dose-related manner

Küppers, E.; Beyer, C., 2001:
Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells

Magill, P.J.; Bolam, J.P.; Bevan, M.D., 2001:
Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network

Han Gui Chun; Mcmillin, P.J.P.; White, R.E., 2000:
Dopamine relaxes porcine coronary arteries and stimulates potassium channel activity in porcine coronary arterial smooth muscle cells

Walker, Q.D.; Rooney, M.B.; Wightman, R.M.; Kuhn, C.M., 2000:
Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry

Cragg, S.J.; Hille, C.J.; Greenfield, S.A., 2000:
Dopamine release and uptake dynamics within nonhuman primate striatum in vitro

Nurmi, M.; Sinclair, J.D.vid; Kiianmaa, K., 1998:
Dopamine release during ethanol drinking in AA rats

Goerendt, I.K.; Messa, C.; Lawrence, A.D.; Grasby, P.M.; Piccini, P.; Brooks, D.J., 2003:
Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study

Del Arco, A.; Segovia, G.; Mora, F., 2001:
Dopamine release during stress in the prefrontal cortex of the rat decreases with age

Yavich, L.; Macdonald, E., 2000:
Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting

D.L.F.ente Fernandez, R.; Phillips, A.G.; Zamburlini, M.; Sossi, V.; Calne, D.B.; Ruth, T.J.; Stoessl, A.J.n, 2002:
Dopamine release in human ventral striatum and expectation of reward

Ito, R.; Dalley, J.W.; Robbins, T.W.; Everitt, B.J., 2002:
Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue

Matuszewich, L.; Lorrain, D.S.; Hull, E.M., 2000:
Dopamine release in the medial preoptic area of female rats in response to hormonal manipulation and sexual activity

Del Arco, A.; Mora, F., 2001:
Dopamine release in the prefrontal cortex during stress is reduced by the local activation of glutamate receptors

Hesselink, M.B.; De-Boer, A.G.; Breimer, D.D.; Danysz, W., 1999:
Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: A microdialysis study in rats

Hauber, W.; Fuchs, H., 2000:
Dopamine release in the rat globus pallidus characterised by in vivo microdialysis

Xie Junxia; Jiang Hong; Chen Wenfang; Qian Zhong Ming, 2003:
Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease

Heimer, G.; Bar-Gad, I.; Goldberg, J.A.; Bergman, H., 2002:
Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism

Zocchi, A.; Girlanda, E.; Varnier, G.; Sartori, I.; Zanetti, L.; Wildish, G.A.; Lennon, M.; Mugnaini, M.; Heidbreder, C.A., 2003:
Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse

Saldías, F.J.; Lecuona, E.; Comellas, A.P.; Ridge, K.M.; Sznajder, J.I., 1999:
Dopamine restores lung ability to clear edema in rats exposed to hyperoxia

Hansard, M.J.; Smith, L.A.; Jackson, M.J.; Cheetham, S.C.; Jenner, P., 2002:
Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primates

Burkey, A.R.; Carstens, E.; Jasmin, L., 1999:
Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception

Federici, M.; Natoli, S.; Bernardi, G.; Mercuri, N.B., 2002:
Dopamine selectively reduces GABAB transmission onto dopaminergic neurones by an unconventional presynaptic action

Karasawa, F.; Okuda, T.; Tsutsui, M.; Matsuoka, N.; Yamada, S.; Kawatani, Y.; Satoh, T., 2003:
Dopamine stabilizes milrinone-induced changes in heart rate and arterial pressure during anaesthesia with isoflurane

Rohr, O.; Sawaya, B.E.; Lecestre, D.; Aunis, D.; Schaeffer, E., 1999:
Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system

Luo, Y.; Kokkonen, G.C.; Hattori, A.; Chrest, F.J.; Roth, G.S., 1999:
Dopamine stimulates redox-tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells

Grossman, M.; Glosser, G.; Kalmanson, J.; Morris, J.; Stern, M.B.; Hurtig, H.I., 2001:
Dopamine supports sentence comprehension in Parkinson's disease

Haskó, Görgy.; Szabó, C.; Németh, Zán.H.; Deitch, E.A., 2002:
Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism

Maher, B.S.; Marazita, M.L.; Ferrell, R.E.; Vanyukov, M.M., 2002:
Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis

Carr, D.B.; O'Donnell, P.; Card, J.P.; Sesack, S.R., 1999:
Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens

Carr, D.B.; Sesack, S.R., 2000:
Dopamine terminals synapse on callosal projection neurons in the rat prefrontal cortex

Johnson, J., R.; Robinson, B., L.; Ali, S., F.; Binienda, Z., 2000:
Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats

Stokes, A.H.; Lewis, D.Y.; Lash, L.H.; Jerome, W.G.ay, IIi; Grant, K.W.; Aschner, M.; Vrana, K.E., 2000:
Dopamine toxicity in neuroblastoma cells: Role of glutathione depletion by L-BSO and apoptosis

Augood, S.J.; Hollingsworth, Z.; Albers, D.S.; Yang, L.; Leung, J-C.; Muller, B.; Klein, C.; Breakefield, X.O.; Standaert, D.G., 2002:
Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study

Sulzer, D.; Galli, A., 2003:
Dopamine transport currents are promoted from curiosity to physiology

Mash, D.C.; Pablo, J.; Ouyang, Q.; Hearn, W.L.e; Izenwasser, S., 2002:
Dopamine transport function is elevated in cocaine users

Hamano, T.; Tsuchida, T.; Hirayama, M.; Fujiyama, J.; Mutoh, T.; Yonekura, Y.; Kuriyama, M., 2000 :
Dopamine transporter SPECT in patients with Parkinson's disease

Hoffman, A.F.; Lupica, C.R.; Gerhardt, G.A., 1998:
Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices

Repo, E.; Kuikka, J.T.; Bergstrom, K.A.; Karhu, J.; Hiltunen, J.; Tiihonen, J., 1999:
Dopamine transporter and D2-receptor density in late-onset alcoholism

Cowell, R.M.; Kantor, L.; Hewlett, G.H.K.ikilani; Frey, K.A.; Gnegy, M.E., 2000:
Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes

Laine, T.P.kka J.; Ahonen, A.; Rasanen, P.; Tiihonen, J., 1999:
Dopamine transporter availability and depressive symptoms during alcohol withdrawal

Mueller Vahl, K.R.; Berding, G.; Bruecke, T.; Kolbe, H.; Meyer, G.J.; Hundeshagen, H.; Dengler, R.; Knapp, W.H.; Emrich, H.M., 2000:
Dopamine transporter binding in Gilles de la Tourette syndrome

Huang, C-Chang.; Chu, N-Shin.; Yen, T-Chen.; Wai, Y-Yau.; Lu, C-Song., 2003:
Dopamine transporter binding in Wilson's disease

Parkinson Study Group, 2002:
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

Yen, T-Chen.; Tzen, K-Yuan.; Chen, M-Chi.; Chou, Y-Huei.Wu.; Chen, R-Shayn.; Chen, C-Jen.; Wey, S-Pyng.; Ting, G.; Lu, C-Song., 2002:
Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers

Laine, T.P.kka, J.; Ahonen, A.; Rasanen, P.; Tiihonen, J., 2001 :
Dopamine transporter density and novelty seeking among alcoholics

Dougherty, D.D.; Bonab, A.A.; Spencer, T.J.; Rauch, S.L.; Madras, B.K.; Fischman, A.J., 1999:
Dopamine transporter density in patients with attention deficit hyperactivity disorder

Lavalaye, J.; Sarlet, A.; Booij, J.; Linszen, D.H.; Reneman, L.; Gersons, B.P.; van Royen, E.A., 2001:
Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study

Holzschuh, J.; Ryu, S.; Aberger, F.; Driever, W., 2001:
Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo

Van Kampen, J.M.; McGeer, E.G.; Stoessl, A.J., 2000:
Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity

Georgieva, L.; Dimitrova, A.; Nikolov, I.; Koleva, S.; Tsvetkova, R.; Owen, M.J.; Toncheva, D.; Kirov, G., 2002:
Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: Family-based association study in the Bulgarian population

Roman, T.; Szobot, C.; Martins, S.; Biederman, J.; Rohde, L.A.; Hutz, M.H., 2002:
Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder

Rohde, L.A.; Roman, T.; Szobot, C.; Cunha, R.D.; Hutz, M.H.; Biederman, J., 2003:
Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study

Lewis, D.A.; Melchitzky, D.S.; Sesack, S.R.; Whitehead, R.E.; Auh, S.; Sampson, A., 2001:
Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization

Caronti, B.; Antonini, G.; Calderaro, C.; Ruggieri, S.; Palladini, G.; Pontieri, F.E.; Colosimo, C., 2001:
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease

Bergstrom, K.A.; Tupala, E.; Tiihonen, J., 2001:
Dopamine transporter in vitro binding and in vivo imaging in the brain

Fernagut, P.O.; Diguet, E.; Jaber, M.; Bioulac, B.; Tison, F., 2002:
Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage

Eberling, J.L.; Bankiewicz, K.S.; Pivirotto, P.; Bringas, J.; Chen, K.; Nowotnik, D.P.; Steiner, J.P.; Budinger, T.F.; Jagust, W.J., 1999:
Dopamine transporter loss and clinical changes in MPTP-lesioned primates

Chen, L.; Segal, D.M.; Moraes, C.T.; Mash, D.C., 1999:
Dopamine transporter mRNA in autopsy studies of chronic cocaine users

Lin, Z.; Uhl, G.R., 2002:
Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism

Young, S.E.; Smolen, A.; Corley, R.P.; Krauter, K.S.; Defries, J.C.; Crowley, T.J.; Hewitt, J.K., 2002:
Dopamine transporter polymorphism associated with externalizing behavior problems in children

Lin, Z.; Itokawa, M.; Uhl, G.R., 2000:
Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression

Kimmel, H.L.; Carroll, F.I.y; Kuhar, M.J., 2000:
Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76

Itokawa, M.; Lin, Z.; Cai, N.S.; Wu, C.; Kitayama, S.; Wang, J.B.; Uhl, G.R., 2000:
Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions

Lin, Z.; Wang, W.; Uhl, G.R., 2000:
Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains

Yatin, S.M.; Miller, G.M.; Norton, C.; Madras, B.K., 2002:
Dopamine transporter-dependent induction of C-Fos in HEK cells

Melchitzky, D.S.; Lewis, D.A., 2001:
Dopamine transporter-immunoreactive axons in the mediodorsal thalamic nucleus of the macaque monkey

Ma, S.Y.; Ciliax, B.J.; Stebbins, G.; Jaffar, S.; Joyce, J.N.; Cochran, E.J.; Kordower, J.H.; Mash, D.C.; Levey, A.I.; Mufson, E.J., 1999:
Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra

Lin, Z.; Wang, W.; Kopajtic, T.; Revay, R.S.; Uhl, G.R., 1999:
Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition

Foster, J.D.; Pananusorn, B.; Cervinski, M.A.; Holden, H.E.; Vaughan, R.A., 2003:
Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1

Foster, J.D.; Pananusorn, B.; Vaughan, R.A., 2002:
Dopamine transporters are phosphorylated on N-terminal serines in rat striatum

Stamm, C.; Friehs, I.; Cowan, D.B.; Cao-Danh, H.; Choi, Y-Hoon.; Duebener, L.F.; McGowan, F.X.; del Nido, P.J., 2002:
Dopamine treatment of postischemic contractile dysfunction rapidly induces calcium-dependent pro-apoptotic signaling

Melnikova, V.; Orosco, M.; Calas, A.; Sapronova, A.; Gainetdinov, R.; Delhaye Bouchaud, N.; Nicolaidis, S.; Rayevsky, K.; Ugrumov, M., 1999:
Dopamine turnover in the mediobasal hypothalamus in rat fetuses

Ho, M.; Segre, M., 2000:
Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine

Rabey, J.M.rtin; Amir, I.; Treves, T.A.; Oberman, Z.; Korczyn, A.D., 1998:
Dopamine uptake by platelet storage granules in first-degree relatives of Tourette's syndrome patients

Morón, J.A.; Brockington, A.; Wise, R.A.; Rocha, B.A.; Hope, B.T., 2002:
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

Mizoguchi, M.B.; Chu, T.G.; Murphy, F.M.; Willits, N.; Morse, L.S., 1999:
Dopamine use is an indicator for the development of threshold retinopathy of prematurity

Basu, S.; Dasgupta, P.S.rathi, 2000:
Dopamine, a neurotransmitter, influences the immune system

See, R.E.; Kruzich, P.J.; Grimm, J.W., 2001:
Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior

Hansard, M.J.; Smith, L.A.; Jackson, M.J.; Cheetham, S.C.; Jenner, P., 2002:
Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates

Buerk, D.G.; Osanai, S.; Mokashi, A.; Lahiri, S., 1998:
Dopamine, sensory discharge, and stimulus interaction with CO2 and O2 in cat carotid body

Kozicz, T.; Arimura, A., 2002:
Dopamine- and cyclic AMP-regulated phosphoprotein-immunoreactive neurons activated by acute stress are innervated by fiber terminals immunopositive for pituitary adenylate cyclase-activating polypeptide in the extended amygdala in the rat

Sanada, H.; Jose, P.A.; Hazen-Martin, D.; Yu, P.Y.; Xu, J.; Bruns, D.E.; Phipps, J.; Carey, R.M.; Felder, R.A., 1999:
Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension

Banihashemi, B.; Albert, P.R., 2002:
Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements

D.P.rada, M.P.ig; Parada, M.A.; Rada, P.; Hernandez, L.; Hoebel, B.G., 2000:
Dopamine-acetylcholine interaction in the rat lateral hypothalamus in the control of locomotion

Kim, D.S.; Szczypka, M.S.; Palmiter, R.D., 2000:
Dopamine-deficient mice are hypersensitive to dopamine receptor agonists

Arai, R.; Horiike, K.; Hasegawa, Y., 1998:
Dopamine-degrading activity of monoamine oxidase is not detected by histochemistry in neurons of the substantia nigra pars compacta of the rat

Williams, D.; Tijssen, M.; Van Bruggen, G.; Bosch, A.; Insola, A.; Di Lazzaro, V.; Mazzone, P.; Oliviero, A.; Quartarone, A.; Speelman, H.; Brown, P., 2002:
Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans

Choi, H.J.n; Kim, S.W.o; Lee, S.Y.on; Hwang, O., 2003:
Dopamine-dependent cytotoxicity of tetrahydrobiopterin: A possible mechanism for selective neurodegeneration in Parkinson's disease

Kim, D.S.; Froelick, G.J.; Palmiter, R.D., 2002 :
Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum

Chartoff, E., H.; Papadopoulou, M.; Konradi, C.; Carlezon, W., A.J., 2003:
Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum

Reynolds, J.N.J.; Wickens, J.R., 2002:
Dopamine-dependent plasticity of corticostriatal synapses

Lu, L.; Liu, Z.; Huang, M.; Zhang, Z., 2003:
Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes

Suzuki, T.; Miura, M.; Nishimura, K.; Aosaki, T., 2001:
Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons

Naoi, M.; Maruyama, W.; Akao, Y.; Yi, H., 2002:
Dopamine-derived endogenous N-methyl-(R)-salsolinol: Its role in Parkinson's disease

Kiyatkin, E.A.; Rebec, G.V., 2000:
Dopamine-independent action of cocaine on striatal and accumbal neurons

Cornish, J.L.; Nakamura, M.; Kalivas, P.W., 2001:
Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area

Jones, D.C.; Gunasekar, P.G.; Borowitz, J.L.; Isom, G.E., 2000:
Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells

Chibalin, A.V.; Ogimoto, G.; Pedemonte, C.H.; Pressley, T.A.; Katz, A.I.; Féraille, E.; Berggren, P.O.; Bertorello, A.M., 1999:
Dopamine-induced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and Is responsible for the decreased activity in epithelial cells

Topchyan, A.V.; Balasanyan, M.G.; Gan'shina, T.S.; Mirzoyan, P.S., 1999:
Dopamine-induced enhacing of cerebral microcirculation in local brain ischemia

Ridge, K.M.; Dada, L.; Lecuona, E.; Bertorello, A.M.; Katz, A.I.; Mochly-Rosen, D.; Sznajder, J.I., 2002:
Dopamine-induced exocytosis of Na,K-ATPase is dependent on activation of protein kinase C-epsilon and -delta

Grima, G.; Benz, B.; Parpura, V.; Cuenod, M.; Do, K.Q., 2003:
Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia

Nowicki, S.; Kruse, M.S.; Brismar, H.; Aperia, A., 2000:
Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells

Gerfen, C.R., 2000:
Dopamine-mediated gene regulation in models of Parkinson's disease

Banday, A.Ahmad.; Asghar, M.; Hussain, T.; Lokhandwala, M.F., 2003:
Dopamine-mediated inhibition of renal Na,K-ATPase is reduced by insulin

Onn, S.P.i; West, A.R.; Grace, A.A., 2000:
Dopamine-mediated regulation of striatal neuronal and network interactions

Durstewitz, D.; Seamans, J.K.; Sejnowski, T.J., 2000:
Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex

Cragg, S.J.; Nicholson, C.; Kume-Kick, J.; Tao, L.; Rice, M.E., 2001:
Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake

Offen, D.; Gorodin, S.; Melamed, E.; Hanania, J.; Malik, Z., 1999:
Dopamine-melanin is actively phagocytized by PC12 cells and cerebellar granular cells: Possible implications for the etiology of Parkinson's disease

Stepien, K.; Zajdel, A.; Wilczok, A.; Wilczok, T.; Grzelak, A.; Mateja, A.; Soszynski, M.; Bartosz, G., 2000:
Dopamine-melanin protects against tyrosine nitration, tryptophan oxidation and Ca2+-ATPase inactivation induced by peroxynitrite

Mavridis, M.; Besson, M.J., 1999:
Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression

Unterwald, E.M.; Cuntapay, M., 2000:
Dopamine-opioid interactions in the rat striatum: A modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction

Mizoguchi, K.; Yuzurihara, M.; Nagata, M.; Ishige, A.; Sasaki, H.; Tabira, T., 2002:
Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment

Calon, F.; Tahar, A.H.dj; Blanchet, P.J.; Morissette, M.; Grondin, R.; Goulet, M.; Doucet, J.P.erre; Robertson, G.S.; Nestler, E.; D.P.olo, T.; Bedard, P.J., 2000:
Dopamine-receptor stimulation: biobehavioral and biochemical consequences

Sy, C.; Airriess, C.N., 2002:
Dopamine-stimulated limb autotomy in the Dungeness crab, Cancer magister

Szczypka, M.S.; Zhou, Q.Y.; Palmiter, R.D., 1998:
Dopamine-stimulated sexual behavior is testosterone dependent in mice

Tupala, E.; Hall, H.; Särkioja, T.; Räsänen, P.; Tiihonen, J., 2000:
Dopamine-transporter density in nucleus accumbens of type-1 alcoholics

Gatley, S.J.hn; Volkow, N.D.; Gifford, A.N.; Fowler, J.S.; Dewey, S.L.; Ding, Y.S.in; Logan, J., 1999:
Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans

Xu, J.; Li, X.X.; Albrecht, F.E.; Hopfer, U.; Carey, R.M.; Jose, P.A., 2000:
Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension

Kakade, S.; Dayan, P., 2002:
Dopamine: Generalization and bonuses

Lehmann, T.; Huebner, H.; Gmeiner, P., 2001:
Dopaminergic 7-aminotetrahydroindolizines: Ex-chiral pool synthesis and preferential D3 receptor binding

Fumagalli, F.; Bedogni, F.; Maragnoli, M.Elisabetta.; Gennarelli, M.; Perez, J.; Racagni, G.; Riva, M.Andrea., 2003:
Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus

Lin, J.Y.; Lipski, J., 2001:
Dopaminergic substantia nigra neurons express functional nmda receptors in postnatal rats

Klimek, V.; Schenck, J.E.; Han, H.; Stockmeier, C.A.; Ordway, G.A., 2002:
Dopaminergic abnormalities in amygdaloid nuclei in major depression: A postmortem study

Piggott, M.A.; Marshall, E.F.; Thomas, N.; Lloyd, S.; Court, J.A.; Jaros, E.; Costa, D.; Perry, R.H.; Perry, E.K., 1999:
Dopaminergic activities in the human striatum: Rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine

Cyr, M.; Morissette, M.; Barden, N.; Beaulieu, S.; Rochford, J.; D.P.olo, T., 2001:
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: Effect of antidepressants

Relja, M.; Klepac, N.; Subotic, Z., 2002:
Dopaminergic agonist and cognitive function in Parkinson's disease

Bina, K.G.; Cincotta, A.H., 2000:
Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice

Fujieda, H.; Scher, J.; Hamadanizadeh, S.A.; Wankiewicz, E.; Pang, S.F.; Brown, G.M., 2000:
Dopaminergic and GABAergic amacrine cells are direct targets of melatonin: immunocytochemical study of mt1 melatonin receptor in guinea pig retina

Besheer, J.; Short, K.R.; Bevins, R.A., 2001:
Dopaminergic and cholinergic antagonism in a novel-object detection task with rats

Desai, R.I.; Barber, D.J.; Terry, P., 2003:
Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats

Coiro, V.; Volpi, R.; Cataldo, S.; Capretti, L.; Caffarri, G.; Pilla, S.; Chiodera, P., 2000:
Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH

Adachi, K.; Hasegawa, M.; Fujita, S.; Sato, M.; Miwa, Y.; Ikeda, H.; Koshikawa, N.; Cools, A.R., 2002:
Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents

Besson, A.; Privat, A.M.; Eschalier, A.; Fialip, J., 1999:
Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm

Uzbay, I.T.; Usanmaz, S.E.; Tapanyigit, E.E.; Aynacioglu, S.; Akarsu, E.S., 1998:
Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: Association with behavioral signs

Benedetti, F.; Campori, E.; Barbini, B.; Fulgosi, M.C.gala; Colombo, C., 2001:
Dopaminergic augmentation of sleep deprivation effects in bipolar depression

Chun, H.S.; Gibson, G.E.; Degiorgio, L.A.; Zhang, H.; Kidd, V.J.; Son, J.H., 2001:
Dopaminergic cell death induced by MPP+, oxidant and specific neurotoxicants shares the common molecular mechanism

He, Y.; Thong, P.S.; Lee, T.; Leong, S.K.; Mao, B.Y.; Dong, F.; Watt, F., 2003:
Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys

Francois, C.; Yelnik, J.; Tande, D.; Agid, Y.; Hirsch, E.C., 1999:
Dopaminergic cell group A8 in the monkey: Anatomical organization and projections to the striatum

Klein, R.L.; King, M.A.; Hamby, M.E.; Meyer, E.M., 2002:
Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra

Toledo Aral, J.J.se; Mendez Ferrer, S.; Pardal, R.; Lopez Barneo, J., 2002:
Dopaminergic cells of the carotid body: Physiological significance and possible therapeutic applications in Parkinson's disease

Kish, S.J.; Kalasinsky, K.S.; Schmunk, G.; Furukawa, Y.; Guttman, M.; Ang, L., 2001:
Dopaminergic changes in human brain following acute exposure to gamma-hydroxybutyrate

Antal, A.; Kéri, S.; Kincses, Z.Tamás.; Dibó, G.; Szabó, A.; Benedek, G.; Janka, Z.; Vécsei, L., 2003:
Dopaminergic contributions to the visual categorization of natural scenes: evidence from Parkinson's disease

Sansoe, G.; Ferrari, A.; Baraldi, E.; Castellana, C.N.ves; Biava, A.; Silvano, S.; Rosina, F.; Bonardi, L.; Manenti, F., 2002:
Dopaminergic control of renal tubular function in patients with compensated cirrhosis

Centonze, D.; Picconi, B.; Gubellini, P.; Bernardi, G.; Calabresi, P., 2001:
Dopaminergic control of synaptic plasticity in the dorsal striatum

Kostrzewa, R.M.; Kostrzewa, J.P.; Brus, R., 2000:
Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum

Honey, G.D.; Suckling, J.; Zelaya, F.; Long, C.; Routledge, C.; Jackson, S.; Ng, V.; Fletcher, P.C.; Williams, S.C.R.; Brown, J.; Bullmore, E.T., 2003:
Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system